<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29023536</article-id><article-id pub-id-type="pmc">5638289</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0185879</article-id><article-id pub-id-type="publisher-id">PONE-D-17-24312</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biomechanics</subject><subj-group><subject>Hand Strength</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Public and Occupational Health</subject><subj-group><subject>Physical Activity</subject><subj-group><subject>Physical Fitness</subject><subj-group><subject>Exercise</subject><subj-group><subject>Strength Training</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Sports and Exercise Medicine</subject><subj-group><subject>Exercise</subject><subj-group><subject>Strength Training</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Sports Science</subject><subj-group><subject>Sports and Exercise Medicine</subject><subj-group><subject>Exercise</subject><subj-group><subject>Strength Training</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Blood Cells</subject><subj-group><subject>White Blood Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Population Groupings</subject><subj-group><subject>Age Groups</subject><subj-group><subject>Elderly</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System</subject><subj-group><subject>Innate Immune System</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System</subject><subj-group><subject>Innate Immune System</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Developmental Biology</subject><subj-group><subject>Molecular Development</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Lipids</subject><subj-group><subject>Fats</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Geriatrics</subject><subj-group><subject>Frailty</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Change in inflammatory parameters in prefrail and frail persons obtaining physical training and nutritional support provided by lay volunteers: A randomized controlled trial</article-title><alt-title alt-title-type="running-head">A lifestyle program provided by volunteers</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Haider</surname><given-names>Sandra</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9605-1467</contrib-id><name><surname>Grabovac</surname><given-names>Igor</given-names></name><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Winzer</surname><given-names>Eva</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kapan</surname><given-names>Ali</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schindler</surname><given-names>Karin Emmi</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lackinger</surname><given-names>Christian</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Titze</surname><given-names>Sylvia</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dorner</surname><given-names>Thomas Ernst</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Social and Preventive Medicine, Centre for Public Health, Medical University of Vienna; Austria</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Internal Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna; Austria</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department for Health Promotion and Prevention, SPORTUNION; Vienna, Austria</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Institute of Sport Science, University of Graz; Graz, Austria</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>van Wouwe</surname><given-names>Jacobus P.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>TNO, NETHERLANDS</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>igor.grabovac@meduniwien.ac.at</email></corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>12</volume><issue>10</issue><elocation-id>e0185879</elocation-id><history><date date-type="received"><day>27</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>11</day><month>9</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 Haider et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Haider et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0185879.pdf"/><abstract><p>The aim of the study was to compare the effects of home visits with physical training and nutritional support on inflammatory parameters to home visits with social support alone within a randomized controlled trial. Prefrail and frail persons received home visits from lay volunteers twice a week for 12 weeks. Participants in the physical training and nutritional intervention group (PTN, n = 35) conducted two sets of six strength exercises and received nutritional support. The social support group (SoSu, n = 23) received visits only. TNF-&#x003b1;, IL-6, CRP, and total leukocyte count were assessed at baseline and after 12 weeks. Changes over time within groups were analyzed with paired t-tests; differences between groups were analyzed with ANCOVA for repeated measurements. In the PTN group, IL-6 and CRP remained stable, whereas in the SoSu group, IL-6 increased significantly from a median value of 2.6 pg/l (min&#x02013;max = 2.0&#x02013;10.2) to 3.0 pg/l (min&#x02013;max = 2.0&#x02013;20.8), and CRP rose from 0.2 mg/dl (min&#x02013;max = 0.1&#x02013;0.9) to 0.3 mg/dl (min&#x02013;max = 0.1&#x02013;3.0) after 12 weeks. In CRP, a significant difference between groups was found. TNF-&#x003b1; and total leukocyte count did not change in either the PTN group or the SoSu group. Persons showing an increase in physical performance (OR 4.54; 95% CI = 1.33&#x02013;15.45) were more likely to have constant or decreased IL-6 values than persons who showed no improvement. In conclusion, in non-robust older adults, a physical training and nutritional support program provided by lay volunteers can delay a further increase in some inflammatory parameters.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001821</institution-id><institution>Vienna Science and Technology Fund</institution></institution-wrap></funding-source><award-id>LS12-039</award-id><principal-award-recipient><name><surname>Dorner</surname><given-names>Thomas Ernst</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported by the `Vienna Science and Technology Fund' (grant number: LS12-039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="4"/><page-count count="16"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Cross-sectional studies have shown that the geriatric syndrome of frailty is linked to increased inflammatory parameters [<xref rid="pone.0185879.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0185879.ref002" ref-type="bibr">2</xref>]. Accordingly, tumor necrosis factor alpha (TNF-&#x003b1;) [<xref rid="pone.0185879.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0185879.ref004" ref-type="bibr">4</xref>], interleukin 6 (IL-6) [<xref rid="pone.0185879.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pone.0185879.ref008" ref-type="bibr">8</xref>], C-reactive protein (CRP) [<xref rid="pone.0185879.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0185879.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0185879.ref008" ref-type="bibr">8</xref>&#x02013;<xref rid="pone.0185879.ref010" ref-type="bibr">10</xref>], and total leukocyte count [<xref rid="pone.0185879.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0185879.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0185879.ref008" ref-type="bibr">8</xref>] are higher in frail persons than in robust persons. As lower muscle mass and muscle strength, poor physical performance, and decreased functional abilities are associated with higher immediate inflammatory parameters in older adults, these factors might influence chronic inflammation [<xref rid="pone.0185879.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0185879.ref012" ref-type="bibr">12</xref>]. In very old and frail individuals, however, muscle mass is not related to TNF-&#x003b1;, IL-6, and CRP [<xref rid="pone.0185879.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0185879.ref014" ref-type="bibr">14</xref>], and physical performance has only a limited association with IL-6 and CRP [<xref rid="pone.0185879.ref015" ref-type="bibr">15</xref>]. It has also been shown that chronic inflammation in older persons can result in a future decrease in muscle mass [<xref rid="pone.0185879.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0185879.ref017" ref-type="bibr">17</xref>], higher incidence of physical disabilities [<xref rid="pone.0185879.ref018" ref-type="bibr">18</xref>], diabetes mellitus [<xref rid="pone.0185879.ref019" ref-type="bibr">19</xref>], hypertension and myocardial infarction [<xref rid="pone.0185879.ref015" ref-type="bibr">15</xref>], ischemic stroke and transient attacks [<xref rid="pone.0185879.ref020" ref-type="bibr">20</xref>], as well as all-cause mortality [<xref rid="pone.0185879.ref021" ref-type="bibr">21</xref>].</p><p>Cross-sectional studies have demonstrated that physical activity is inversely associated with chronic inflammatory parameters in older persons [<xref rid="pone.0185879.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0185879.ref023" ref-type="bibr">23</xref>], with biochemical changes in muscles or in body composition (e.g. a decline in fat mass) being the likely cause [<xref rid="pone.0185879.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0185879.ref024" ref-type="bibr">24</xref>]. Nonetheless, the exact mechanism is not currently known [<xref rid="pone.0185879.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0185879.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0185879.ref025" ref-type="bibr">25</xref>], and the effects of a physical and nutritional intervention on inflammatory parameters in older persons have only been examined in a few intervention studies, with controversial results. For example, a study in obese frail persons found that a 12-week program had no effect on TNF- &#x003b1; and IL-6 levels [<xref rid="pone.0185879.ref026" ref-type="bibr">26</xref>]. In another study in obese older persons with knee osteoarthritis, where frailty was not an inclusion criterion, a decrease in IL-6 and CRP but not in TNF-&#x003b1; was shown after 6 months. In addition, a decrease in IL-6 with no change in CRP was found in adults at risk of disability [<xref rid="pone.0185879.ref027" ref-type="bibr">27</xref>]. This decline in IL-6 is also in line with a study of persons older than 60 years participating in a strength training program [<xref rid="pone.0185879.ref028" ref-type="bibr">28</xref>].</p><p>Besides physical activity, body composition and some macro- and micro-nutrients influence the inflammatory parameters. In overweight and obese individuals, it has been convincingly demonstrated that weight loss reduces CRP and IL-6 [<xref rid="pone.0185879.ref029" ref-type="bibr">29</xref>]. The reduction in fat mass, which decreases IL-6 and in turn lowers CRP, might be the underlying reason for this [<xref rid="pone.0185879.ref030" ref-type="bibr">30</xref>]. These effects only apply to obese persons, and findings in prefrail and frail subjects are broadly missing. Polyphenols, which occur in vegetables and fruits [<xref rid="pone.0185879.ref031" ref-type="bibr">31</xref>&#x02013;<xref rid="pone.0185879.ref033" ref-type="bibr">33</xref>], and the supplementation of oleic and alpha-linolenic acid, have also been shown to have anti-inflammatory effects [<xref rid="pone.0185879.ref029" ref-type="bibr">29</xref>]. The influences of saturated and trans-fatty acids, cholesterol, soy intake, vitamin D, and whey supplements are conflicting [<xref rid="pone.0185879.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0185879.ref034" ref-type="bibr">34</xref>], while most studies have shown that fish oil supplementation does not have any effect [<xref rid="pone.0185879.ref029" ref-type="bibr">29</xref>].</p><p>In a previously published paper, we looked at the effects of the intervention on handgrip strength, which was our main outcome parameter. We demonstrated that home visits with physical training and nutritional support provided by lay volunteers can increase handgrip strength significantly, with no significant difference to home visits with social support alone [<xref rid="pone.0185879.ref035" ref-type="bibr">35</xref>]. Fat mass and appendicular muscle mass were neither affected by home visits with physical training and nutritional intervention nor by home visits with social support alone. Up to now, it is not known whether such an intervention can also affect inflammatory parameters. Therefore, the aim of the present paper was to examine the effects of home visits with physical training and nutritional support carried out by lay volunteers on inflammatory parameters, and to compare them to the effects of home visits with social support alone. In addition, we aimed to examine the association between inflammatory parameters and baseline values of body composition, handgrip strength, and physical performance. A further purpose was to look at parameters associated with constant or decreased inflammatory parameters within 12 weeks.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><p>The study includes data from a randomized controlled trial that took place in Vienna from September 2013 to July 2015, Austria. Recruitment was undertaken between 09/2013 and 10/2014; last follow-up assessment was conducted in 02/2015. The study complies with the Declaration of Helsinki [<xref rid="pone.0185879.ref036" ref-type="bibr">36</xref>]. Ethical approval was given by the ethical committee of the Medical University of Vienna (ref: 1416/2013; date: 27.08.2013), and written informed consent was obtained from all participants. The protocol was registered at ClinicalTrials.gov (identifier: NCT01991639). All ongoing and related trials were also registered. The study protocol, also describing the sample size calculation, which is based on the main outcome of handgrip strength, has previously been published [<xref rid="pone.0185879.ref037" ref-type="bibr">37</xref>]. Based on this calculation (two-sided t-test, significance level = 0.05, power = 80%, differences between the groups: 2 kg with a standard deviation of 3 kg), we aimed to include 40 participants in each group. Randomization was done with the help of the Randomizer for Clinical Trials 1.8.1 [<xref rid="pone.0185879.ref038" ref-type="bibr">38</xref>]. In this paper, we focus on changes in inflammatory parameters, which was prospectively defined as a secondary outcome.</p><sec id="sec003"><title>Participants</title><sec id="sec004"><title>Prefrail or frail individuals</title><p>The inclusion and exclusion criteria have previously been described in the study protocol [<xref rid="pone.0185879.ref037" ref-type="bibr">37</xref>]. Community-dwelling prefrail or frail individuals according to the Survey of Health, Ageing and Retirement in Europe (SHARE-FI) were included [<xref rid="pone.0185879.ref039" ref-type="bibr">39</xref>]. The SHARE-FI includes the items of &#x0201c;exhaustion&#x0201d;, &#x0201c;loss of appetite&#x0201d;, &#x0201c;weakness&#x0201d;, &#x0201c;slowness&#x0201d;, and &#x0201c;low physical activity&#x0201d;. The ratings of the five items are summarized to form a discrete factor score (DFS). As at least &#x0201c;pre-frailty&#x0201d; was an inclusion criterion of this study, women with a DFS of &#x0003e;0.315 and men with a DFS of &#x0003e;1.212 were included [<xref rid="pone.0185879.ref037" ref-type="bibr">37</xref>]. In addition, persons at least at risk of malnutrition according to the Mini Nutritional Assessment Short-Form (MNA-SF &#x02264;11 points) were included [<xref rid="pone.0185879.ref040" ref-type="bibr">40</xref>]. Further inclusion criteria were: resident in Vienna and older than 65 years [<xref rid="pone.0185879.ref037" ref-type="bibr">37</xref>]. Individuals with: insulin-treated diabetes mellitus, chronic obstructive pulmonary disease stage III or IV, chronic kidney insufficiency with protein restriction, or chemo- or radio-therapy during the study period were excluded. Persons with insufficient German language skills, impaired cognitive function according to the Mini-Mental State Examination (MMSE &#x02264;17 points) [<xref rid="pone.0185879.ref041" ref-type="bibr">41</xref>], or any contraindication for physical training were also excluded. In addition to these criteria, we also excluded individuals with any acute infection at baseline from the analyses of this paper. These individuals met the following two criteria: 1) an acute infection was defined as an illness with a rapid onset, leading to a substantial decrease in health during the last month leading up to baseline [<xref rid="pone.0185879.ref042" ref-type="bibr">42</xref>]; and 2) excluded persons had high inflammatory parameters at baseline, which then decreased strongly during the study period. At the very beginning of the study, the study team tried to recruit patients at three different hospitals in internal medicine wards. As this recruitment mode was not successful, patients were recruited through two editorial features, one in the local newspaper and one on television, describing the content of the study. Inclusion criteria were then checked by the study team.</p></sec><sec id="sec005"><title>Buddies</title><p>Prefrail or frail individuals were visited by a lay-volunteer called a &#x0201c;buddy&#x0201d;. These buddies were recruited through notices in newspapers and had to be older than 50 years. Prior to inclusion, the buddies received detailed information about the study during an information evening. Furthermore, their intention to take part in the study was checked within a structured interview by a psychologist.</p></sec></sec><sec id="sec006"><title>Intervention</title><sec id="sec007"><title>Training of the buddies</title><p>Before the home visits were started, buddies received four training sessions, each with a mean duration of 3 hours. These training sessions were performed by a multidisciplinary team consisting of sports and nutritional scientists, physiotherapists, dieticians, psychologists, and medical doctors. Discussed themes included: the ageing process, frailty, malnutrition, and physical activity in older adults. In addition, buddies were trained in the implementation of the physical training and nutritional intervention.</p><p>The study consisted of two study groups:</p><list list-type="bullet"><list-item><p><underline>Physical training and nutritional intervention (PTN) group</underline>: As sarcopenia and malnutrition contribute to the frailty syndrome, physical training (especially strength training) and nutritional intervention play a relevant role in tackling frailty [<xref rid="pone.0185879.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0185879.ref044" ref-type="bibr">44</xref>]. Therefore, participants were asked to perform 6&#x02212;10 strength exercises with 1&#x02212;3 sets and 18&#x02212;20 repetitions in circuit form at least twice a week [<xref rid="pone.0185879.ref045" ref-type="bibr">45</xref>]. In addition, a diet sufficient in energy, protein, and micronutrients was required [<xref rid="pone.0185879.ref046" ref-type="bibr">46</xref>, <xref rid="pone.0185879.ref047" ref-type="bibr">47</xref>].</p><p>Based on this knowledge, the PTN group received physical training and nutritional support twice a week. In detail, participants performed a warm-up session with mobilization exercises, followed by six strength exercises, which were performed in circuit form. The following exercises were conducted: 1) mini squats in front of a chair; 2) chest presses against elastic resistance; 3) an exercise for the abdominal muscles performed in sitting position; 4) hip extensions in standing position; 5) reverse butterfly; and 6) shoulder presses against elastic resistance. This circuit was conducted twice with 15 repetitions until muscular exhaustion. If the participants could not perform an exercise due to physical limitations, the exercise was skipped.</p><p>During these home visits, three main nutritional messages were also discussed, which were aimed at improving fluid, protein, and energy intake. Fruit, vegetable, and cereal intake was also addressed. For this purpose, buddies were provided with a portfolio describing the recommended intake, the relevance, as well as implementation possibilities. Participants were also provided with the Healthy for Life Plate [<xref rid="pone.0185879.ref037" ref-type="bibr">37</xref>], a modification of the Healthy Eating Plate [<xref rid="pone.0185879.ref048" ref-type="bibr">48</xref>], which shows the differences between recommended and actual food intake. Participants were also provided with a recipe book, which included ideas for protein-rich dishes.</p></list-item><list-item><p><underline>Social support (SoSu) group</underline>: Participants in the SoSu group received home visits without physical training and nutritional support. They were allowed to spend their time as they wanted (e.g. they were free to talk with the buddy about everyday things or they could conduct cognitive training).</p></list-item></list></sec></sec><sec id="sec008"><title>Measurements</title><p>The following measurements were conducted at baseline and after 12 weeks:</p><sec id="sec009"><title>Inflammatory parameters</title><p>Blood was taken by a mobile laboratory at the home of the frail participants. The time of the blood draw was not standardized. However, it was ensured that blood was not taken within 8 hours of exercise training. The following inflammatory parameters were obtained: TNF-&#x003b1; (pg/ml) and IL-6 (pg/ml) using chemiluminescent immunoassay, CRP (mg/dl) using immunoturbidimetry, and total leukocyte count (g/l). In this paper, parameters are shown as metric variables. In addition, TNF-&#x003b1;, IL-6, and CRP were dichotomized as &#x0201c;normal&#x0201d; or &#x0201c;elevated&#x0201d; values according to the cut-off values for very old community-dwelling individuals (women = TNF-&#x003b1;: 3.0 pg/ml; IL-6: 1.4 pg/ml; CRP: 0.1 mg/dl; men = TNF-&#x003b1;: 3.3 pg/ml; IL-6: 1.8 pg/ml; CRP: 0.1 mg/dl) [<xref rid="pone.0185879.ref013" ref-type="bibr">13</xref>]. Total leukocyte counts were also dichotomized [<xref rid="pone.0185879.ref049" ref-type="bibr">49</xref>].</p></sec><sec id="sec010"><title>Body mass index (BMI)</title><p>In order to assess BMI (kg/m<sup>2</sup>), body weight was determined with a Marsden MS-4203&#x000ae; calibrated scale (Rotherham, UK) and body height was measured with a tape.</p></sec><sec id="sec011"><title>Fat mass (FM), appendicular skeletal muscle mass (ASMM), and phase angle</title><p>These three parameters were assessed with a phase-sensitive bioelectrical impedance analysis (BIA) device (BIA 2000-S, Data Input&#x000ae;, Darmstadt, Germany) in lying position with four electrodes [<xref rid="pone.0185879.ref050" ref-type="bibr">50</xref>]. Within this method, an alternating current is sent through the body, measuring body resistance (R) and reactance (X<sub>c</sub>). FM in kg was calculated by subtracting fat-free mass from body weight. Fat-free mass was calculated with the validated Geneva formula [&#x02212;4.104 + (0.518 &#x000d7; height<sup>2</sup>/resistance) + (0.231 &#x000d7; weight) + (0.130 &#x000d7; reactance) + (4.229 &#x000d7; sex: men = 1, women = 0)] [<xref rid="pone.0185879.ref051" ref-type="bibr">51</xref>], as it is known to be the best available method in individuals aged &#x02265;65 years [<xref rid="pone.0185879.ref052" ref-type="bibr">52</xref>].</p><p>ASMM in kg was calculated using the validated formula of Sergi et al. [&#x02013;3.964 +(0.227 &#x000d7; height<sup>2</sup>/R) + (0.095 &#x000d7; weight) + (1.384 &#x000d7; sex) +(0.064 &#x000d7; X<sub>c</sub>)] [<xref rid="pone.0185879.ref053" ref-type="bibr">53</xref>]. To obtain relative values in kg/m<sup>2</sup>, the absolute values were divided by body height in meters, resulting in the fat mass index (FMI) and appendicular skeletal muscle mass index (ASMMI). In addition, phase angle [R/ X<sub>c</sub> &#x000d7;180&#x000b0;/ &#x003c0;] was taken from the BIA device.</p></sec><sec id="sec012"><title>Handgrip strength</title><p>Maximum handgrip strength in kg was measured using a JAMAR&#x000ae; handheld dynamometer (Lafayette, Louisiana), for both hands, three times each. For this purpose, participants were seated with their arms bent at the elbow, and they were required to grip with maximal effort [<xref rid="pone.0185879.ref054" ref-type="bibr">54</xref>]. The maximum value achieved was noted. In addition, relative handgrip strength in kg/m<sup>2</sup> was calculated by dividing absolute values by body height.</p></sec><sec id="sec013"><title>Physical performance</title><p>Physical performance was assessed with the Short Physical Performance Battery (SPPB) [<xref rid="pone.0185879.ref055" ref-type="bibr">55</xref>]. In this test, balance, gait speed, and five timed chair stands are assessed. The lowest reachable value is 0 points; the best value is 12 points.</p></sec><sec id="sec014"><title>Comorbidities</title><p>The information about existing comorbidities is based on self-reports, and was verified with the daily medication records. The Charlson comorbidity index (CI) was calculated by summing the weighted comorbidities, and adding a score for the age [<xref rid="pone.0185879.ref056" ref-type="bibr">56</xref>]. Participants were divided into individuals with &#x0201c;mild comorbidities&#x0201d; (CI &#x0003c;2), &#x0201c;moderate comorbidities&#x0201d; (2&#x02264; CI &#x02264;4), and &#x0201c;severe comorbidities&#x0201d; (CI &#x02265;5).</p></sec><sec id="sec015"><title>Medication</title><p>The information about currently taken medication is based on the delivered drug packages. The name of the patient and the daily dose were noted. As drugs with anti-inflammatory effects influence inflammatory parameters, individuals were classified into persons taking medication with anti-inflammatory effects and persons who did not. Drugs with the following chemical agents were classified as anti-inflammatory drugs: ciclesonide, dexibuprofen, diclofenac, fluticasone-<ext-link ext-link-type="uri" xlink:href="http://www.dict.cc/englisch-deutsch/propionate.html">propionate</ext-link>, ibuprofen, lornoxicam, mefenamic acid, meloxicam, naproxen, and prednisone. The total number of drugs taken and the intake of anti-inflammatory drugs (yes, no) are presented in this paper.</p></sec><sec id="sec016"><title>Adherence</title><p>The information about the adherence to the intervention was noted in documentation forms by the buddies. Frequency and duration of the home visits, numbers of circuits, exercises, and repetitions were noted. Furthermore, the content and the numbers of nutritional interventions were recorded. The number of training sessions between home visits was also noted.</p></sec></sec><sec id="sec017"><title>Statistical methods</title><p>The normal distribution of the included data was checked with histograms and box plots. Continuous normally distributed data are presented as the mean (standard deviation) and skewed data as the median (minimum&#x02013;maximum). Categorical variables are shown as frequencies (percentages). In order to test the differences between the PTN and the SoSu group at baseline in continuous normally distributed data, we used unpaired t-tests. For the skewed data, Mann-Whitney U-tests were applied. For categorical data with values below five in any of the cells, Fisher&#x02019;s exact tests were performed.</p><p>Analyses on the inflammatory parameters were performed on a per-protocol approach. Due to the fact that the IL-6 and CRP values were skewed, we made a log-transformation before starting with the analyses over time. Changes within groups were analyzed with paired t-tests; differences between groups were assessed with analysis of covariance (ANCOVA) for repeated measurements. To obtain unbiased results, these analyses were adjusted for baseline value [<xref rid="pone.0185879.ref057" ref-type="bibr">57</xref>]. In addition, we adjusted for sex, age, anti-inflammatory medication, and chronic rheumatism, as these parameters are known to influence inflammatory parameters [<xref rid="pone.0185879.ref058" ref-type="bibr">58</xref>, <xref rid="pone.0185879.ref059" ref-type="bibr">59</xref>]. Linear regression analyses were applied to examine the association between the baseline values of frailty status, BMI, FMI, ASMMI, phase angle, relative handgrip strength, physical performance, and inflammatory parameters. In these analyses, patients who were lost to follow-up were included, leading to a sample size of 73 persons. As in the analyses over time, these calculations were also adjusted for sex, age, anti-inflammatory medication, and chronic rheumatism. Finally, we performed binary logistic regression analyses to examine whether the baseline values of frailty status, handgrip strength, and physical performance were associated with detected changes in inflammatory parameters. For this purpose, changes in inflammatory parameters were dichotomized into &#x0201c;constant or decreased inflammatory parameters&#x0201d; (&#x02264;0.00 units) or &#x0201c;increased inflammatory parameters&#x0201d; (&#x0003e;0.00 units). The dichotomized variable was used as the dependent variable. In the same way, we analyzed, if &#x0201c;constant or decreased inflammatory parameters&#x0201d; were related to &#x0201c;constant or decreased&#x0201d; frailty status (&#x02264;0.00 DFS score), &#x0201c;increased&#x0201d; handgrip strength (&#x0003e;0.00 kg), and &#x0201c;increased&#x0201d; physical performance (&#x0003e;0.00 points). These analyses were adjusted for sex, age, anti-inflammatory medication, chronic rheumatism, and group [<xref rid="pone.0185879.ref058" ref-type="bibr">58</xref>, <xref rid="pone.0185879.ref059" ref-type="bibr">59</xref>]. The analyses were performed with IBM&#x000ae; SPSS&#x000ae; Statistics Version 20 software (IBM Corp., Armonk, NY, U.S.). A p-value of &#x0003c;0.05 was considered to be statistically significant.</p></sec></sec><sec sec-type="results" id="sec018"><title>Results</title><p><xref ref-type="fig" rid="pone.0185879.g001">Fig 1</xref> presents the participant flow.</p><fig id="pone.0185879.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0185879.g001</object-id><label>Fig 1</label><caption><title>Participant flow.</title></caption><graphic xlink:href="pone.0185879.g001"/></fig><p>In total, 482 individuals were checked for eligibility. Only four (5.0%) persons recruited from hospital were included, because 73.0% did not meet the inclusion criteria, 19.2% declined participation, and 6.8% were excluded for other reasons. The remaining 76 (95.0%) adults were recruited with the help of the media. Finally, 39 participants were randomized to the PTN group and 41 to the SoSu group. At the 12-week follow-up, a drop-out rate of 14 (17.5%) subjects was observed, and two (2.5%) participants had to be excluded because the blood tests were not available at baseline. We also excluded six (7.5%) participants due to acute diseases at baseline. Reported diseases were cases of herpes zoster, gastric ulcer, bronchitis, and respiratory infection. In addition, two other (1.6%) participants were excluded because the laboratory tests at baseline were not carried out, due to organizational issues. In addition, two (1.6%) individuals performed physical training and talked about nutrition, although they were assigned to the SoSu group; therefore, they were analyzed in the PTN group. Finally, the 35 members of the PTN group and the 23 members of the SoSu group were analyzed.</p><p>The baseline characteristics of the included participants are presented in <xref ref-type="table" rid="pone.0185879.t001">Table 1</xref>.</p><table-wrap id="pone.0185879.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0185879.t001</object-id><label>Table 1</label><caption><title>Baseline characteristics of the study sample.</title></caption><alternatives><graphic id="pone.0185879.t001g" xlink:href="pone.0185879.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Physical training and nutritional<break/>intervention group</th><th align="center" rowspan="1" colspan="1">Social<break/>support<break/>group</th><th align="center" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">n = 35</td><td align="center" rowspan="1" colspan="1">n = 23</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Female, n (%)</td><td align="center" rowspan="1" colspan="1">30 (85.7)</td><td align="center" rowspan="1" colspan="1">19 (82.6)</td><td align="center" rowspan="1" colspan="1">0.876</td></tr><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">83.1 (7.8)</td><td align="center" rowspan="1" colspan="1">81.4 (8.7)</td><td align="center" rowspan="1" colspan="1">0.433</td></tr><tr><td align="left" rowspan="1" colspan="1">Frailty status (SHARE-FI score)</td><td align="center" rowspan="1" colspan="1">2.8 (1.1)</td><td align="center" rowspan="1" colspan="1">2.9 (0.9)</td><td align="center" rowspan="1" colspan="1">0.664</td></tr><tr><td align="left" rowspan="1" colspan="1">Nutritional status (MNA&#x000ae;-SF score)</td><td align="center" rowspan="1" colspan="1">11.2 (2.5)</td><td align="center" rowspan="1" colspan="1">10.5 (2.5)</td><td align="center" rowspan="1" colspan="1">0.281</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">27.5 (5.0)</td><td align="center" rowspan="1" colspan="1">27.0 (3.0)</td><td align="center" rowspan="1" colspan="1">0.608</td></tr><tr><td align="left" rowspan="1" colspan="1">Fat mass index (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">10.5 (3.5)</td><td align="center" rowspan="1" colspan="1">10.6 (2.4)</td><td align="center" rowspan="1" colspan="1">0.936</td></tr><tr><td align="left" rowspan="1" colspan="1">Appendicular skeletal muscle mass index (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">6.8 (1.2)</td><td align="center" rowspan="1" colspan="1">6.3 (0.8)</td><td align="center" rowspan="1" colspan="1">0.081</td></tr><tr><td align="left" rowspan="1" colspan="1">Phase angle (&#x000b0;)</td><td align="center" rowspan="1" colspan="1">4.0 (0.6)</td><td align="center" rowspan="1" colspan="1">4.0 (0.7)</td><td align="center" rowspan="1" colspan="1">0.957</td></tr><tr><td align="left" rowspan="1" colspan="1">Handgrip strength (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">17.6 (7.4)</td><td align="center" rowspan="1" colspan="1">16.8 (6.80)</td><td align="center" rowspan="1" colspan="1">0.687</td></tr><tr><td align="left" rowspan="1" colspan="1">Physical performance (SPPB score)</td><td align="center" rowspan="1" colspan="1">5.2 (2.7)</td><td align="center" rowspan="1" colspan="1">4.3 (3.0)</td><td align="center" rowspan="1" colspan="1">0.229</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Inflammatory parameters</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Tumor necrosis factor alpha (pg/ml)</td><td align="center" rowspan="1" colspan="1">10.2 (3.4)</td><td align="center" rowspan="1" colspan="1">10.1 (2.7)</td><td align="center" rowspan="1" colspan="1">0.825</td></tr><tr><td align="left" rowspan="1" colspan="1">Interleukin-6 (pg/ml)</td><td align="center" rowspan="1" colspan="1">2.6 (2.0&#x02013;17.2)</td><td align="center" rowspan="1" colspan="1">2.6 (2.0&#x02013;30.6)</td><td align="center" rowspan="1" colspan="1">0.951</td></tr><tr><td align="left" rowspan="1" colspan="1">C-reactive protein (mg/dl)</td><td align="center" rowspan="1" colspan="1">0.2 (0.1&#x02013;1.7)</td><td align="center" rowspan="1" colspan="1">0.2 (0.1&#x02013;5.6)</td><td align="center" rowspan="1" colspan="1">0.639</td></tr><tr><td align="left" rowspan="1" colspan="1">Leukocytes total (g/l)</td><td align="center" rowspan="1" colspan="1">7.0 (2.0)</td><td align="center" rowspan="1" colspan="1">6.9 (1.7)</td><td align="center" rowspan="1" colspan="1">0.904</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Comorbidities</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Arthritis, n (%)</td><td align="center" rowspan="1" colspan="1">8 (22.9)</td><td align="center" rowspan="1" colspan="1">2 (8.7)</td><td align="center" rowspan="1" colspan="1">0.287</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic rheumatism, n (%)</td><td align="center" rowspan="1" colspan="1">4 (11.4)</td><td align="center" rowspan="1" colspan="1">2 (8.7)</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">Cancer, n (%)</td><td align="center" rowspan="1" colspan="1">3 (8.6)</td><td align="center" rowspan="1" colspan="1">3 (13.0)</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension, n (%)</td><td align="center" rowspan="1" colspan="1">28 (80.0)</td><td align="center" rowspan="1" colspan="1">15 (65.2)</td><td align="center" rowspan="1" colspan="1">0.796</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial infarction, n (%)</td><td align="center" rowspan="1" colspan="1">3 (8.6)</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart insufficiency, n (%)</td><td align="center" rowspan="1" colspan="1">9 (25.7)</td><td align="center" rowspan="1" colspan="1">5 (21.7)</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke, n (%)</td><td align="center" rowspan="1" colspan="1">6 (17.1)</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td><td align="center" rowspan="1" colspan="1">0.226</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus type 2, n (%)</td><td align="center" rowspan="1" colspan="1">4 (11.4)</td><td align="center" rowspan="1" colspan="1">5 (21.7)</td><td align="center" rowspan="1" colspan="1">0.460</td></tr><tr><td align="left" rowspan="1" colspan="1">Charlson comorbidity (index)</td><td align="center" rowspan="1" colspan="1">5.2 (1.5)</td><td align="center" rowspan="1" colspan="1">5.3 (1.5)</td><td align="center" rowspan="1" colspan="1">0.618</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Medications</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Numbers of different drugs per day</td><td align="center" rowspan="1" colspan="1">8 (0&#x02013;16)</td><td align="center" rowspan="1" colspan="1">8 (0&#x02013;19)</td><td align="center" rowspan="1" colspan="1">0782</td></tr><tr><td align="left" rowspan="1" colspan="1">Anti-inflammatory medication, n (%) <xref ref-type="table-fn" rid="t001fn003"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">11 (31.4)</td><td align="center" rowspan="1" colspan="1">5 (21.7)</td><td align="center" rowspan="1" colspan="1">0.419</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Continuous data are presented as mean (standard deviation) or median (minimum&#x02013;maximum), categorical variables as frequencies (percentages). <italic>SHARE-FI =</italic> Frailty Instrument of the Survey of Health, Ageing and Retirement in Europe; <italic>MNA&#x000ae;-SF</italic> = Mini Nutritional Assessment Short-Form; <italic>SPPB</italic> = Short Physical Performance Battery.</p></fn><fn id="t001fn002"><p><sup>a</sup> Values are based on t-tests or Mann-Whitney U-tests (continuous variables) and Fisher&#x02019;s exact test (categorical variables).</p></fn><fn id="t001fn003"><p><sup>b</sup> Including medications with the following chemical agents: ciclesonide, dexibuprofen, diclofenac, fluticasone-<ext-link ext-link-type="uri" xlink:href="http://www.dict.cc/englisch-deutsch/propionate.html">propionate</ext-link>, ibuprofen, lornoxicam, mefenamic acid, meloxicam, naproxen, and prednisone.</p></fn></table-wrap-foot></table-wrap><p>Among the participants, 84.8% were females, with a mean age of 82.4 years and a standard deviation (SD) of 8.2; 38 (65.5%) were frail; 19 (32.8%) were prefrail; and one (1.6%) was robust but at risk of malnutrition. BMI was calculated as 27.3 (SD = 4.3) kg/m<sup>2</sup>, FMI as 10.6 (SD = 3.1) kg and ASMMI as 6.6 (SD = 1.0) kg. Mean handgrip strength was 17.3 (SD = 7.1) kg, and physical performance came to 4.8 (SD = 2.8) points. In total, 100% of the participants had elevated TNF-&#x003b1;, 100% had elevated IL-6 values, and in 62.1%, CRP levels were increased. Five (8.2%) participants had total leukocyte counts out of the normal ranges. According to the CI, 63.2% of the participants had severe comorbidities. The remaining 36.8% had moderate comorbidities. These participants took a mean average of eight (min&#x02013;max = 0&#x02013;19) different drugs per day. There was no difference in any baseline characteristic between those who completed the study and those who were lost to follow-up (data not shown).</p><p>Documentation forms showed no difference between the two groups in frequency and duration of the home visits. The PTN group performed a mean average of 1.3 strength circuits (SD = 0.5) consisting of 5.5 exercises (SD = 0.8). A mean average of 12.2 repetitions (SD = 3.9) was conducted. In addition, seven participants (17%) performed strength circuits between the home visits. In respect to nutritional intervention, a mean average of 1 (SD = 0.6) intervention was performed.</p><p>The analyses over time, from baseline to 12 weeks, showed that TNF-&#x003b1; increased in 62.1% and total leukocyte count in 60.3% of the participants. Furthermore, IL-6 increased in 62.1% of the individuals, whereas in the SoSu group, an increase from a median value of 2.6 pg/l (min&#x02013;max = 2.0&#x02013;10.2) to 3.0 pg/l (min&#x02013;max = 2.0&#x02013;20.8) was found. CRP rose in 36.2%, whereas in the SoSu group, an increase from a median value of 0.2 mg/dl (min&#x02013;max = 0.1&#x02013;0.9) to 0.3 mg/l (min&#x02013;max = 0.1&#x02013;3.0) was seen. Further results showed that, in the PTN group, log-IL-6 and log-CRP remained constant, whereas in the SoSu group, these parameters increased significantly (<xref ref-type="table" rid="pone.0185879.t002">Table 2</xref>). Concerning CRP, we also saw a significant difference between groups. TNF-&#x003b1; and total leucocyte count did not change in either of the groups.</p><table-wrap id="pone.0185879.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0185879.t002</object-id><label>Table 2</label><caption><title>Changes in inflammatory parameters from baseline to 12 weeks.</title></caption><alternatives><graphic id="pone.0185879.t002g" xlink:href="pone.0185879.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" style="border-top:thick" rowspan="1" colspan="1"/><th align="justify" style="border-top:thick" rowspan="1" colspan="1"/><th align="center" colspan="2" style="border-top:thick" rowspan="1">Differences<break/>over time<xref ref-type="table-fn" rid="t002fn002"><sup>a</sup></xref></th><th align="center" style="border-top:thick" rowspan="1" colspan="1">Differences<break/>between groups<xref ref-type="table-fn" rid="t002fn003"><sup>b</sup></xref></th></tr><tr><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean change (95% CI)</th><th align="center" rowspan="1" colspan="1">p-value</th><th align="center" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">TNF-&#x003b1; (pg/ml)</td><td align="left" rowspan="1" colspan="1">PTN</td><td align="center" rowspan="1" colspan="1">&#x02212;0.32 (&#x02212;1.24&#x02013;0.38)</td><td align="center" rowspan="1" colspan="1">0.287</td><td align="center" rowspan="2" colspan="1">0.469</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">SoSu</td><td align="center" rowspan="1" colspan="1">&#x02212;0.47 (&#x02212;1.40&#x02013;0.46)</td><td align="center" rowspan="1" colspan="1">0.303</td></tr><tr><td align="left" rowspan="1" colspan="1">Log-IL-6 (pg/ml)</td><td align="left" rowspan="1" colspan="1">PTN</td><td align="center" rowspan="1" colspan="1">0.11 (&#x02212;0.11&#x02013;0.33)</td><td align="center" rowspan="1" colspan="1">0.304</td><td align="center" rowspan="2" colspan="1">0.343</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">SoSu</td><td align="center" rowspan="1" colspan="1">0.19 (0.00&#x02013;0.37)</td><td align="center" rowspan="1" colspan="1">0.047</td></tr><tr><td align="left" rowspan="1" colspan="1">Log-CRP (mg/dl)</td><td align="left" rowspan="1" colspan="1">PTN</td><td align="center" rowspan="1" colspan="1">0.08 (&#x02212;0.16&#x02013;0.32)</td><td align="center" rowspan="1" colspan="1">0.501</td><td align="center" rowspan="2" colspan="1">0.040</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">SoSu</td><td align="center" rowspan="1" colspan="1">0.46 (0.07&#x02013;0.85)</td><td align="center" rowspan="1" colspan="1">0.022</td></tr><tr><td align="left" rowspan="1" colspan="1">Leukocytes total (g/l)</td><td align="left" rowspan="1" colspan="1">PTN</td><td align="center" rowspan="1" colspan="1">0.48 (&#x02212;0.04&#x02013;1.01)</td><td align="center" rowspan="1" colspan="1">0.070</td><td align="center" rowspan="2" colspan="1">0.839</td></tr><tr><td align="left" style="border-bottom:thick" rowspan="1" colspan="1"/><td align="left" style="border-bottom:thick" rowspan="1" colspan="1">SoSu</td><td align="center" style="border-bottom:thick" rowspan="1" colspan="1">0.46 (&#x02212;0.22&#x02013;1.13)</td><td align="center" style="border-bottom:thick" rowspan="1" colspan="1">0.177</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p><italic>PTN</italic> = physical training and nutritional intervention group (n = 35); <italic>SoSu</italic> = social support group (n = 23).</p></fn><fn id="t002fn002"><p><sup>a</sup> Differences over time were calculated using paired t-tests. Mean change and 95% confidence interval (95% CI) are presented.</p></fn><fn id="t002fn003"><p><sup>b</sup> Differences between groups were calculated using analysis of covariance (ANCOVA) for repeated measurements, adjusted for baseline value, sex, age, anti-inflammatory medication, and chronic rheumatism.</p></fn></table-wrap-foot></table-wrap><p>As presented in <xref ref-type="table" rid="pone.0185879.t003">Table 3</xref>, higher frailty status at baseline was associated with higher TNF-&#x003b1;. Lower handgrip strength was related to higher log-IL-6 and better physical performance with lower CRP values. Current BMI, FMI, ASMMI, phase angle, and physical performance were not associated with any inflammatory parameter.</p><table-wrap id="pone.0185879.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0185879.t003</object-id><label>Table 3</label><caption><title>Association between baseline values of inflammatory parameters and baseline values of body composition parameters, handgrip strength, and physical performance.</title></caption><alternatives><graphic id="pone.0185879.t003g" xlink:href="pone.0185879.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">TNF-&#x003b1;<break/>(pg/ml)</th><th align="center" colspan="2" rowspan="1">Log-IL-6<break/>(pg/ml)</th><th align="center" colspan="2" rowspan="1">Log-CRP<xref ref-type="table-fn" rid="t003fn002">*</xref><break/>(mg/dl)</th><th align="center" colspan="2" rowspan="1">Leukocytes total<break/>(g/l)</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">&#x000df;</th><th align="center" rowspan="1" colspan="1">0070</th><th align="center" rowspan="1" colspan="1">&#x000df;</th><th align="center" rowspan="1" colspan="1">p-value</th><th align="center" rowspan="1" colspan="1">&#x000df;</th><th align="center" rowspan="1" colspan="1">p-value</th><th align="center" rowspan="1" colspan="1">&#x000df;</th><th align="center" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Frailty status (SHARE-FI)</td><td align="center" rowspan="1" colspan="1"><bold>0.360</bold></td><td align="center" rowspan="1" colspan="1"><bold>0.002</bold></td><td align="center" rowspan="1" colspan="1">0.183</td><td align="center" rowspan="1" colspan="1">0.117</td><td align="center" rowspan="1" colspan="1">0.021</td><td align="center" rowspan="1" colspan="1">0.889</td><td align="center" rowspan="1" colspan="1">&#x02212;0.056</td><td align="center" rowspan="1" colspan="1">0.645</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">0.173</td><td align="center" rowspan="1" colspan="1">0.207</td><td align="center" rowspan="1" colspan="1">0.140</td><td align="center" rowspan="1" colspan="1">0.302</td><td align="center" rowspan="1" colspan="1">0.228</td><td align="center" rowspan="1" colspan="1">0.105</td><td align="center" rowspan="1" colspan="1">0.188</td><td align="center" rowspan="1" colspan="1">0.171</td></tr><tr><td align="left" rowspan="1" colspan="1">Fat mass index (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">0.241</td><td align="center" rowspan="1" colspan="1">0.117</td><td align="center" rowspan="1" colspan="1">0.142</td><td align="center" rowspan="1" colspan="1">0.353</td><td align="center" rowspan="1" colspan="1">0.234</td><td align="center" rowspan="1" colspan="1">0.137</td><td align="center" rowspan="1" colspan="1">0.243</td><td align="center" rowspan="1" colspan="1">0.115</td></tr><tr><td align="left" rowspan="1" colspan="1">ASMMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">0.127</td><td align="center" rowspan="1" colspan="1">0.357</td><td align="center" rowspan="1" colspan="1">0.084</td><td align="center" rowspan="1" colspan="1">0.536</td><td align="center" rowspan="1" colspan="1">0.218</td><td align="center" rowspan="1" colspan="1">0.123</td><td align="center" rowspan="1" colspan="1">0.075</td><td align="center" rowspan="1" colspan="1">0.589</td></tr><tr><td align="left" rowspan="1" colspan="1">Phase angle (&#x000b0;)</td><td align="center" rowspan="1" colspan="1">&#x02212;0.188</td><td align="center" rowspan="1" colspan="1">0.137</td><td align="center" rowspan="1" colspan="1">&#x02212;0.242</td><td align="center" rowspan="1" colspan="1">0.052</td><td align="center" rowspan="1" colspan="1">0.169</td><td align="center" rowspan="1" colspan="1">0.198</td><td align="center" rowspan="1" colspan="1">0.038</td><td align="center" rowspan="1" colspan="1">0.766</td></tr><tr><td align="left" rowspan="1" colspan="1">Handgrip strength (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">&#x02212;0.149</td><td align="center" rowspan="1" colspan="1">0.233</td><td align="center" rowspan="1" colspan="1"><bold>&#x02212;0.237</bold></td><td align="center" rowspan="1" colspan="1"><bold>0.047</bold></td><td align="center" rowspan="1" colspan="1">0.043</td><td align="center" rowspan="1" colspan="1">0.748</td><td align="center" rowspan="1" colspan="1">&#x02212;0.043</td><td align="center" rowspan="1" colspan="1">0.732</td></tr><tr><td align="left" rowspan="1" colspan="1">Physical performance (SPPB)</td><td align="center" rowspan="1" colspan="1">&#x02212;0.239</td><td align="center" rowspan="1" colspan="1">0.051</td><td align="center" rowspan="1" colspan="1">0.085</td><td align="center" rowspan="1" colspan="1">0.480</td><td align="center" rowspan="1" colspan="1"><bold>0.335</bold></td><td align="center" rowspan="1" colspan="1"><bold>0.008</bold></td><td align="center" rowspan="1" colspan="1">0.177</td><td align="center" rowspan="1" colspan="1">0.151</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>In these analyses, patients who were lost to follow-up were also included (n = 73). Values are based on univariate linear regression analyses, with inflammatory parameters as the dependent variables, adjusted for sex, age, anti-inflammatory medication, and chronic rheumatism. Standardized &#x000df;-values are reported.</p></fn><fn id="t003fn002"><p>*As the CRP values become negative numbers after log-transformation, associations appearing as positive must be interpreted as negative associations.</p></fn><fn id="t003fn003"><p><italic>ASMMI</italic> = appendicular skeletal muscle mass index; <italic>SPPB =</italic> Short Physical Performance Battery; <italic>SHARE-FI</italic> = Frailty Instrument of the Survey of Health, Ageing and Retirement in Europe.</p></fn></table-wrap-foot></table-wrap><p>Neither frailty status, handgrip strength, nor physical performance at baseline were associated with a higher chance of having &#x0201c;constant or decreased&#x0201d; inflammatory parameters (<xref ref-type="table" rid="pone.0185879.t004">Table 4</xref>). Furthermore, persons who were able to increase their physical performance within the study had a greater chance of having &#x0201c;constant or decreased&#x0201d; log-IL-6 values compared to persons who could not increase physical performance.</p><table-wrap id="pone.0185879.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0185879.t004</object-id><label>Table 4</label><caption><title>Association between constant or decreased (versus increased) inflammatory parameters within 12 weeks and baseline values/changes in frailty score, handgrip strength, and physical performance.</title></caption><alternatives><graphic id="pone.0185879.t004g" xlink:href="pone.0185879.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" colspan="8" rowspan="1">Constant or decreased</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">TNF-&#x003b1;</th><th align="center" colspan="2" rowspan="1">Log-IL-6</th><th align="center" colspan="2" rowspan="1">Log-CRP</th><th align="center" colspan="2" rowspan="1">Leukocytes total</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">OR (95% CI)</th><th align="center" rowspan="1" colspan="1">p-value</th><th align="center" rowspan="1" colspan="1">OR (95% CI)</th><th align="center" rowspan="1" colspan="1">p-value</th><th align="center" rowspan="1" colspan="1">OR (95% CI)</th><th align="center" rowspan="1" colspan="1">p-value</th><th align="center" rowspan="1" colspan="1">OR (95% CI)</th><th align="center" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BL frailty status (SHARE-FI score)</td><td align="center" rowspan="1" colspan="1">0.79 (0.43&#x02013;1.46)</td><td align="center" rowspan="1" colspan="1">0.447</td><td align="center" rowspan="1" colspan="1">1.18 (0.66&#x02013;2.09)</td><td align="center" rowspan="1" colspan="1">0.570</td><td align="center" rowspan="1" colspan="1">0.62 (0.30&#x02013;1.27)</td><td align="center" rowspan="1" colspan="1">0.194</td><td align="center" rowspan="1" colspan="1">1.14 (0.65&#x02013;2.01)</td><td align="center" rowspan="1" colspan="1">0.642</td></tr><tr><td align="left" rowspan="1" colspan="1">BL handgrip strength (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">0.94 (0.83&#x02013;1.05)</td><td align="center" rowspan="1" colspan="1">0.265</td><td align="center" rowspan="1" colspan="1">0.99 (0.89&#x02013;1.09)</td><td align="center" rowspan="1" colspan="1">0.801</td><td align="center" rowspan="1" colspan="1">1.00 (0.88&#x02013;1.14)</td><td align="center" rowspan="1" colspan="1">0.978</td><td align="center" rowspan="1" colspan="1">0.97 (0.88&#x02013;1.08)</td><td align="center" rowspan="1" colspan="1">0.591</td></tr><tr><td align="left" rowspan="1" colspan="1">BL physical performance (SPPB score)</td><td align="center" rowspan="1" colspan="1">1.09 (0.85&#x02013;1.39)</td><td align="center" rowspan="1" colspan="1">0.495</td><td align="center" rowspan="1" colspan="1">0.96 (0.77&#x02013;1.20)</td><td align="center" rowspan="1" colspan="1">0.720</td><td align="center" rowspan="1" colspan="1">1.16 (0.90&#x02013;1.51)</td><td align="center" rowspan="1" colspan="1">0.262</td><td align="center" rowspan="1" colspan="1">0.97 (0.78&#x02013;1.21)</td><td align="center" rowspan="1" colspan="1">0.798</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>&#x00394; frailty status (SHARE-FI score)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Constant or decreased</td><td align="center" rowspan="1" colspan="1">1.75 (0.45&#x02013;6.79)</td><td align="center" rowspan="1" colspan="1">0.418</td><td align="center" rowspan="1" colspan="1">1.30 (0.40&#x02013;4.29)</td><td align="center" rowspan="1" colspan="1">0.663</td><td align="center" rowspan="1" colspan="1">2.47 (0.56&#x02013;10.93)</td><td align="center" rowspan="1" colspan="1">0.233</td><td align="center" rowspan="1" colspan="1">0.95 (0.29&#x02013;3.11)</td><td align="center" rowspan="1" colspan="1">0.929</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Increased</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>&#x00394; handgrip strength (kg/m</bold><sup>2</sup><bold>)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Constant or decreased</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Increased</td><td align="center" rowspan="1" colspan="1">0.52 (0.15&#x02013;1.84)</td><td align="center" rowspan="1" colspan="1">0.307</td><td align="center" rowspan="1" colspan="1">1.29 (0.42&#x02013;3.93)</td><td align="center" rowspan="1" colspan="1">0.658</td><td align="center" rowspan="1" colspan="1">0.66 (0.17&#x02013;2.51)</td><td align="center" rowspan="1" colspan="1">0.541</td><td align="center" rowspan="1" colspan="1">0.63 (0.21&#x02013;1.93)</td><td align="center" rowspan="1" colspan="1">0.421</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>&#x00394; physical performance (SPPB score)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Constant or decreased</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Increased</td><td align="center" rowspan="1" colspan="1">0.56 (0.16&#x02013;2.03)</td><td align="center" rowspan="1" colspan="1">0.378</td><td align="center" rowspan="1" colspan="1"><bold>4.54 (1.33</bold>&#x02013;<bold>15.45)</bold></td><td align="center" rowspan="1" colspan="1"><bold>0.016</bold></td><td align="center" rowspan="1" colspan="1">0.49 (0.13&#x02013;1.87)</td><td align="center" rowspan="1" colspan="1">0.294</td><td align="center" rowspan="1" colspan="1"><bold>1.37 (0.45&#x02013;4.22)</bold></td><td align="center" rowspan="1" colspan="1"><bold>0.582</bold></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>Values are based on univariate logistic regression analyses, with constant or decreased inflammatory parameters (&#x02264;0.00 units) as dependent variables, adjusted for sex, age, anti-inflammatory medication, chronic rheumatism, and group. Odds ratio (OR) and 95% confidence interval (95% CI) are presented. BL = baseline; SHARE-FI = Frailty Instrument of the Survey of Health, Ageing and Retirement in Europe; SPPB = Short Physical Performance Battery, &#x00394; = changes from baseline to 12 weeks.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="conclusions" id="sec019"><title>Discussion</title><p>The findings of this study showed that IL-6 and CRP remained constant in prefrail and frail participants receiving physical training and nutritional support from trained lay volunteers, whereas in those receiving home visits with social support alone, these parameters increased significantly. In addition, further publications of this intervention demonstrated that home visits with physical training and nutritional support can significantly increase handgrip strength and physical performance, but not muscle mass [<xref rid="pone.0185879.ref060" ref-type="bibr">60</xref>]. There was no significant change in these parameters in participants receiving home visits with social support alone.</p><p>As very old individuals with severe comorbidities were included in the study, a considerable increase in inflammatory parameters was measured, and two participants died (due to natural death) in the short period of 12 weeks. We are only aware of one comparable study of frail individuals [<xref rid="pone.0185879.ref026" ref-type="bibr">26</xref>]. In this study, obesity was an inclusion criterion, and physical training (three times a week, flexibility, aerobic, resistance, balance) in addition to an energy-deficit diet was conducted. Although FM decreased, no change in IL-6 and TNF-&#x003b1; was detected. With respect to this study, and based on the fact that in our study FM remained stable with an increase in IL-6 and CRP in the SoSu group, it can be concluded that a change in FM might not be the cause for the change in inflammatory parameters in prefrail and frail persons. The finding that physical and nutritional training can influence CRP and IL-6, with no effect on TNF-&#x003b1;, is in line with the study of Nicklas et al. [<xref rid="pone.0185879.ref061" ref-type="bibr">61</xref>] conducted in older overweight and obese individuals. In addition, the study participants of Nicklas et al. [<xref rid="pone.0185879.ref061" ref-type="bibr">61</xref>] conducted an exercise program consisting of aerobic and strength training, while our study participants performed strength training only. These different training methods might also affect inflammatory parameters in a different way. Despite this fact, the main difference between their intervention and our study is that the intervention of Nicklas et al. [<xref rid="pone.0185879.ref061" ref-type="bibr">61</xref>] led to a reduction in body weight, whereas in our study, body weight remained stable. This is in addition to the fact that they saw a decrease in CRP and IL-6, whereas we only saw stable values in the PTN group. As, in our study, the CRP and IL-6 of the SoSu group increased with significant between-group differences, we are confident that, in very old individuals with advanced frailty status, stable inflammation values may be considered a success. In line with the justification mentioned in Nicklas et al. [<xref rid="pone.0185879.ref061" ref-type="bibr">61</xref>], the non-significant change in TNF-&#x003b1; might be traced back to the transient production and the short half-life [<xref rid="pone.0185879.ref062" ref-type="bibr">62</xref>].</p><p>Reasons for the significant differences between the PTN group and the SoSu group can only be vaguely formulated. The first possible reason, which has been postulated in earlier research, although considered as rather unlikely, is that a reduction in adipose mass or BMI might lead to a decrease in IL-6 and consequently to decreased CRP production [<xref rid="pone.0185879.ref024" ref-type="bibr">24</xref>]. This hypothesis is not supported by our data, as we did not see any significant change in BMI and FM. The second possible reason, as suggested by Geffken et al. [<xref rid="pone.0185879.ref023" ref-type="bibr">23</xref>], is that physical activity might reduce inflammation by improving insulin resistance. Unfortunately, in the present study, insulin resistance was not assessed. The third possible reason might be that physical activity influences endothelial cells, which secrete IL-6 [<xref rid="pone.0185879.ref063" ref-type="bibr">63</xref>]. With the data of the present study, no statement can be made about this hypothesis. The same applies to a fourth possible reason, which is the suggestion that the downregulation of toll-like receptor-4 in the skeletal muscle might lead to a decrease in mRNA, and declining TNF-&#x003b1; and IL-6 [<xref rid="pone.0185879.ref026" ref-type="bibr">26</xref>]. A fifth possible reason could be that the PTN group increased the uptake of anti-inflammatory nutrients such as polyphenols. However, this hypothesis is rather unlikely as no increase in the fruit and vegetable intake or the Mediterranean diet score [<xref rid="pone.0185879.ref064" ref-type="bibr">64</xref>] was found (data not yet published).</p><p>The non-association between physical performance, muscle mass, and inflammatory parameters is not surprising. These results are in line with the findings of Legrand et al. [<xref rid="pone.0185879.ref013" ref-type="bibr">13</xref>] and Cesari et al. [<xref rid="pone.0185879.ref014" ref-type="bibr">14</xref>]. In addition, in older high-functioning persons, the MacArthur study [<xref rid="pone.0185879.ref015" ref-type="bibr">15</xref>] showed only limited association between physical performance and inflammatory parameters. The authors claimed that the diversity in functional limitations was responsible. Although we included a more homogeneous group, we still did not see a significant association, leading to the conclusion that diversity in disabilities might not be the main reason for the non-association. Our results also showed that in prefrail and frail persons, phase angle is not associated with inflammatory parameters, although it has been shown to be an indicator of cellular death in elderly individuals [<xref rid="pone.0185879.ref065" ref-type="bibr">65</xref>]. Thus, it might be postulated that in elderly persons with poor general health, phase angle is not related to inflammatory parameters. Oxidative stress has been reported to have an association with frailty [<xref rid="pone.0185879.ref066" ref-type="bibr">66</xref>]. However, from the results of our study, no statement about the association between oxidative stress (e.g. lipoprotein phospholipase, isoprostanes) or anti-oxidant parameters (e.g. vitamins C, E, tocopherol, total thiol levels) and frailty can be made.</p><p>To the best of our knowledge, this is the first study of its kind to investigate the effects of physical training and nutritional support on inflammatory parameters in a sample of prefrail and frail community-dwelling older persons, which we consider to be a major strength. In addition, it is the first time that such an intervention was provided by lay volunteers. Despite these strengths, the study also has some limitations. As the sample size calculation is based on the main outcome of handgrip strength, the effects on inflammatory parameters might be underpowered. Furthermore, the small number of participants and the relatively high number lost to follow-up is a further limitation. ASMM and FM were assessed with a BIA device. However, as a distorted hydration status might influence the results, this can be considered as a disadvantage. The fact that IL-6 and CRP have to be log-transformed also made the data difficult to interpret. Although we tried to adjust for possible confounders, it cannot be ruled out that other confounders influence inflammatory parameters. Moreover, it would be better to use highly sensitive CRP. Another limitation is that insulin concentration and mRNA were not assessed. These parameters could give more information about the achieved group differences.</p></sec><sec sec-type="conclusions" id="sec020"><title>Conclusions</title><p>Prefrail and frail older adults should be encouraged to take part in a standardized strength training program in combination with nutritional support provided by lay volunteers, as it might prevent or delay a further increase in IL-6 and CRP. These results are clinically important, as inflammatory parameters are associated with a further decline in skeletal muscle mass, and these parameters predict mortality. An increase in physical performance is particularly important, as it is associated with a higher chance of reaching constant or decreased log-CRP values.</p><p>Further research is needed to examine the physiological process behind the effects of physical training and nutritional support on inflammatory parameters in prefrail and frail older adults.</p></sec><sec sec-type="supplementary-material" id="sec021"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0185879.s001"><label>S1 Dataset</label><caption><title>Dataset from the Medical University of Vienna.</title><p>(SAV)</p></caption><media xlink:href="pone.0185879.s001.sav"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0185879.s002"><label>S1 File</label><caption><title>CONSORT checklist.</title><p>(DOC)</p></caption><media xlink:href="pone.0185879.s002.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0185879.s003"><label>S2 File</label><caption><title>Ethic vote.</title><p>(PDF)</p></caption><media xlink:href="pone.0185879.s003.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0185879.s004"><label>S3 File</label><caption><title>Impact of a home-based physical and nutritional intervention program conducted by lay-volunteers on handgrip strength in prefrail and frail older adults: A randomized control trial.</title><p>(PDF)</p></caption><media xlink:href="pone.0185879.s004.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0185879.s005"><label>S4 File</label><caption><title>Study protocol.</title><p>(PDF)</p></caption><media xlink:href="pone.0185879.s005.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We would like to thank Martin Oberbauer, Melissa Vallant, Sophia Koepruner, Lisa Buchinger, Lisa Penold, and Michaele Ehrenberger for their assistance in conducting the study; Georg Heinze for the support in statistical issues; and Mark Ackerley for the professional proofreading.</p></ack><ref-list><title>References</title><ref id="pone.0185879.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Espinoza</surname><given-names>SE</given-names></name>, <name><surname>Fried</surname><given-names>LP</given-names></name>. <article-title>Risk Factors for Frailty in the Older Adult</article-title>. <source>Clin Geriatr</source>. <year>2007</year>;<volume>15</volume>:<fpage>37</fpage>&#x02013;<lpage>44</lpage>.</mixed-citation></ref><ref id="pone.0185879.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Yao</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Leng</surname><given-names>SX</given-names></name>. <article-title>Inflammation and immune system alterations in frailty</article-title>. <source>Clin Geriatr Med</source>. <year>2011</year>;<volume>27</volume>(<issue>1</issue>):<fpage>79</fpage>&#x02013;<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cger.2010.08.002">10.1016/j.cger.2010.08.002</ext-link></comment> ; PubMed Central PMCID: PMC3011971.<pub-id pub-id-type="pmid">21093724</pub-id></mixed-citation></ref><ref id="pone.0185879.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Hubbard</surname><given-names>RE</given-names></name>, <name><surname>O'Mahony</surname><given-names>MS</given-names></name>, <name><surname>Calver</surname><given-names>BL</given-names></name>, <name><surname>Woodhouse</surname><given-names>KW</given-names></name>. <article-title>Plasma esterases and inflammation in ageing and frailty</article-title>. <source>Eur J Clin Pharmacol</source>. <year>2008</year>;<volume>64</volume>(<issue>9</issue>):<fpage>895</fpage>&#x02013;<lpage>900</lpage>. Epub 2008/05/29. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00228-008-0499-1">10.1007/s00228-008-0499-1</ext-link></comment> .<pub-id pub-id-type="pmid">18506436</pub-id></mixed-citation></ref><ref id="pone.0185879.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Leng</surname><given-names>SX</given-names></name>, <name><surname>Xue</surname><given-names>QL</given-names></name>, <name><surname>Tian</surname><given-names>J</given-names></name>, <name><surname>Walston</surname><given-names>JD</given-names></name>, <name><surname>Fried</surname><given-names>LP</given-names></name>. <article-title>Inflammation and frailty in older women</article-title>. <source>J Am Geriatr Soc</source>. <year>2007</year>;<volume>55</volume>(<issue>6</issue>):<fpage>864</fpage>&#x02013;<lpage>71</lpage>. Epub 2007/06/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1532-5415.2007.01186.x">10.1111/j.1532-5415.2007.01186.x</ext-link></comment> .<pub-id pub-id-type="pmid">17537086</pub-id></mixed-citation></ref><ref id="pone.0185879.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Mao</surname><given-names>G</given-names></name>, <name><surname>Leng</surname><given-names>SX</given-names></name>. <article-title>Frailty syndrome: an overview</article-title>. <source>Clin Interv Aging</source>. <year>2014</year>;<volume>9</volume>:<fpage>433</fpage>&#x02013;<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2147/CIA.S45300">10.2147/CIA.S45300</ext-link></comment> ; PubMed Central PMCID: PMC3964027.<pub-id pub-id-type="pmid">24672230</pub-id></mixed-citation></ref><ref id="pone.0185879.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Hubbard</surname><given-names>RE</given-names></name>, <name><surname>O'Mahony</surname><given-names>MS</given-names></name>, <name><surname>Savva</surname><given-names>GM</given-names></name>, <name><surname>Calver</surname><given-names>BL</given-names></name>, <name><surname>Woodhouse</surname><given-names>KW</given-names></name>. <article-title>Inflammation and frailty measures in older people</article-title>. <source>J Cell Mol Med</source>. <year>2009</year>;<volume>13</volume>(<issue>9B</issue>):<fpage>3103</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1582-4934.2009.00733.x">10.1111/j.1582-4934.2009.00733.x</ext-link></comment> .<pub-id pub-id-type="pmid">19438806</pub-id></mixed-citation></ref><ref id="pone.0185879.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Leng</surname><given-names>S</given-names></name>, <name><surname>Chaves</surname><given-names>P</given-names></name>, <name><surname>Koenig</surname><given-names>K</given-names></name>, <name><surname>Walston</surname><given-names>J</given-names></name>. <article-title>Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study</article-title>. <source>J Am Geriatr Soc</source>. <year>2002</year>;<volume>50</volume>(<issue>7</issue>):<fpage>1268</fpage>&#x02013;<lpage>71</lpage>. Epub 2002/07/23. .<pub-id pub-id-type="pmid">12133023</pub-id></mixed-citation></ref><ref id="pone.0185879.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Soysal</surname><given-names>P</given-names></name>, <name><surname>Stubbs</surname><given-names>B</given-names></name>, <name><surname>Lucato</surname><given-names>P</given-names></name>, <name><surname>Luchini</surname><given-names>C</given-names></name>, <name><surname>Solmi</surname><given-names>M</given-names></name>, <name><surname>Peluso</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Inflammation and frailty in the elderly: A systematic review and meta-analysis</article-title>. <source>Ageing research reviews</source>. <year>2016</year>;<volume>31</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.arr.2016.08.006">10.1016/j.arr.2016.08.006</ext-link></comment> .<pub-id pub-id-type="pmid">27592340</pub-id></mixed-citation></ref><ref id="pone.0185879.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Puts</surname><given-names>MT</given-names></name>, <name><surname>Visser</surname><given-names>M</given-names></name>, <name><surname>Twisk</surname><given-names>JW</given-names></name>, <name><surname>Deeg</surname><given-names>DJ</given-names></name>, <name><surname>Lips</surname><given-names>P</given-names></name>. <article-title>Endocrine and inflammatory markers as predictors of frailty</article-title>. <source>Clinical endocrinology</source>. <year>2005</year>;<volume>63</volume>(<issue>4</issue>):<fpage>403</fpage>&#x02013;<lpage>11</lpage>. Epub 2005/09/27. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1365-2265.2005.02355.x">10.1111/j.1365-2265.2005.02355.x</ext-link></comment> .<pub-id pub-id-type="pmid">16181232</pub-id></mixed-citation></ref><ref id="pone.0185879.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Velissaris</surname><given-names>D</given-names></name>, <name><surname>Pantzaris</surname><given-names>N</given-names></name>, <name><surname>Koniari</surname><given-names>I</given-names></name>, <name><surname>Koutsogiannis</surname><given-names>N</given-names></name>, <name><surname>Karamouzos</surname><given-names>V</given-names></name>, <name><surname>Kotroni</surname><given-names>I</given-names></name>, <etal>et al</etal>
<article-title>C-Reactive Protein and Frailty in the Elderly: A Literature Review</article-title>. <source>Journal of clinical medicine research</source>. <year>2017</year>;<volume>9</volume>(<issue>6</issue>):<fpage>461</fpage>&#x02013;<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.14740/jocmr2959w">10.14740/jocmr2959w</ext-link></comment> ; PubMed Central PMCID: PMC5412518.<pub-id pub-id-type="pmid">28496545</pub-id></mixed-citation></ref><ref id="pone.0185879.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Visser</surname><given-names>M</given-names></name>, <name><surname>Pahor</surname><given-names>M</given-names></name>, <name><surname>Taaffe</surname><given-names>DR</given-names></name>, <name><surname>Goodpaster</surname><given-names>BH</given-names></name>, <name><surname>Simonsick</surname><given-names>EM</given-names></name>, <name><surname>Newman</surname><given-names>AB</given-names></name>, <etal>et al</etal>
<article-title>Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>. <year>2002</year>;<volume>57</volume>(<issue>5</issue>):<fpage>M326</fpage>&#x02013;<lpage>32</lpage>. Epub 2002/05/02. .<pub-id pub-id-type="pmid">11983728</pub-id></mixed-citation></ref><ref id="pone.0185879.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Nicklas</surname><given-names>BJ</given-names></name>, <name><surname>Brinkley</surname><given-names>TE</given-names></name>. <article-title>Exercise training as a treatment for chronic inflammation in the elderly</article-title>. <source>Exerc Sport Sci Rev</source>. <year>2009</year>;<volume>37</volume>(<issue>4</issue>):<fpage>165</fpage>&#x02013;<lpage>70</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/JES.0b013e3181b7b3d9">10.1097/JES.0b013e3181b7b3d9</ext-link></comment> ; PubMed Central PMCID: PMC2789351.<pub-id pub-id-type="pmid">19955865</pub-id></mixed-citation></ref><ref id="pone.0185879.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Legrand</surname><given-names>D</given-names></name>, <name><surname>Adriaensen</surname><given-names>W</given-names></name>, <name><surname>Vaes</surname><given-names>B</given-names></name>, <name><surname>Mathei</surname><given-names>C</given-names></name>, <name><surname>Wallemacq</surname><given-names>P</given-names></name>, <name><surname>Degryse</surname><given-names>J</given-names></name>. <article-title>The relationship between grip strength and muscle mass (MM), inflammatory biomarkers and physical performance in community-dwelling very old persons</article-title>. <source>Arch Gerontol Geriatr</source>. <year>2013</year>;<volume>57</volume>(<issue>3</issue>):<fpage>345</fpage>&#x02013;<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.archger.2013.06.003">10.1016/j.archger.2013.06.003</ext-link></comment> .<pub-id pub-id-type="pmid">23830056</pub-id></mixed-citation></ref><ref id="pone.0185879.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Cesari</surname><given-names>M</given-names></name>, <name><surname>Leeuwenburgh</surname><given-names>C</given-names></name>, <name><surname>Lauretani</surname><given-names>F</given-names></name>, <name><surname>Onder</surname><given-names>G</given-names></name>, <name><surname>Bandinelli</surname><given-names>S</given-names></name>, <name><surname>Maraldi</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study</article-title>. <source>Am J Clin Nutr</source>. <year>2006</year>;<volume>83</volume>(<issue>5</issue>):<fpage>1142</fpage>&#x02013;<lpage>8</lpage>. Epub 2006/05/11. ; PubMed Central PMCID: PMCPMC2668161.<pub-id pub-id-type="pmid">16685058</pub-id></mixed-citation></ref><ref id="pone.0185879.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Taaffe</surname><given-names>DR</given-names></name>, <name><surname>Harris</surname><given-names>TB</given-names></name>, <name><surname>Ferrucci</surname><given-names>L</given-names></name>, <name><surname>Rowe</surname><given-names>J</given-names></name>, <name><surname>Seeman</surname><given-names>TE</given-names></name>. <article-title>Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>. <year>2000</year>;<volume>55</volume>(<issue>12</issue>):<fpage>M709</fpage>&#x02013;<lpage>15</lpage>. Epub 2000/12/29. .<pub-id pub-id-type="pmid">11129392</pub-id></mixed-citation></ref><ref id="pone.0185879.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Aleman</surname><given-names>H</given-names></name>, <name><surname>Esparza</surname><given-names>J</given-names></name>, <name><surname>Ramirez</surname><given-names>FA</given-names></name>, <name><surname>Astiazaran</surname><given-names>H</given-names></name>, <name><surname>Payette</surname><given-names>H</given-names></name>. <article-title>Longitudinal evidence on the association between interleukin-6 and C-reactive protein with the loss of total appendicular skeletal muscle in free-living older men and women</article-title>. <source>Age Ageing</source>. <year>2011</year>;<volume>40</volume>(<issue>4</issue>):<fpage>469</fpage>&#x02013;<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/ageing/afr040">10.1093/ageing/afr040</ext-link></comment> .<pub-id pub-id-type="pmid">21565862</pub-id></mixed-citation></ref><ref id="pone.0185879.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Schaap</surname><given-names>LA</given-names></name>, <name><surname>Pluijm</surname><given-names>SM</given-names></name>, <name><surname>Deeg</surname><given-names>DJ</given-names></name>, <name><surname>Harris</surname><given-names>TB</given-names></name>, <name><surname>Kritchevsky</surname><given-names>SB</given-names></name>, <name><surname>Newman</surname><given-names>AB</given-names></name>, <etal>et al</etal>
<article-title>Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>. <year>2009</year>;<volume>64</volume>(<issue>11</issue>):<fpage>1183</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/gerona/glp097">10.1093/gerona/glp097</ext-link></comment> ; PubMed Central PMCID: PMC2759573.<pub-id pub-id-type="pmid">19622801</pub-id></mixed-citation></ref><ref id="pone.0185879.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Penninx</surname><given-names>BW</given-names></name>, <name><surname>Kritchevsky</surname><given-names>SB</given-names></name>, <name><surname>Newman</surname><given-names>AB</given-names></name>, <name><surname>Nicklas</surname><given-names>BJ</given-names></name>, <name><surname>Simonsick</surname><given-names>EM</given-names></name>, <name><surname>Rubin</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Inflammatory markers and incident mobility limitation in the elderly</article-title>. <source>J Am Geriatr Soc</source>. <year>2004</year>;<volume>52</volume>(<issue>7</issue>):<fpage>1105</fpage>&#x02013;<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1532-5415.2004.52308.x">10.1111/j.1532-5415.2004.52308.x</ext-link></comment> .<pub-id pub-id-type="pmid">15209648</pub-id></mixed-citation></ref><ref id="pone.0185879.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Pradhan</surname><given-names>AD</given-names></name>, <name><surname>Manson</surname><given-names>JE</given-names></name>, <name><surname>Rifai</surname><given-names>N</given-names></name>, <name><surname>Buring</surname><given-names>JE</given-names></name>, <name><surname>Ridker</surname><given-names>PM</given-names></name>. <article-title>C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus</article-title>. <source>JAMA</source>. <year>2001</year>;<volume>286</volume>(<issue>3</issue>):<fpage>327</fpage>&#x02013;<lpage>34</lpage>. Epub 2001/07/24. .<pub-id pub-id-type="pmid">11466099</pub-id></mixed-citation></ref><ref id="pone.0185879.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Rost</surname><given-names>NS</given-names></name>, <name><surname>Wolf</surname><given-names>PA</given-names></name>, <name><surname>Kase</surname><given-names>CS</given-names></name>, <name><surname>Kelly-Hayes</surname><given-names>M</given-names></name>, <name><surname>Silbershatz</surname><given-names>H</given-names></name>, <name><surname>Massaro</surname><given-names>JM</given-names></name>, <etal>et al</etal>
<article-title>Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study</article-title>. <source>Stroke</source>. <year>2001</year>;<volume>32</volume>(<issue>11</issue>):<fpage>2575</fpage>&#x02013;<lpage>9</lpage>. Epub 2001/11/03. .<pub-id pub-id-type="pmid">11692019</pub-id></mixed-citation></ref><ref id="pone.0185879.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Harris</surname><given-names>TB</given-names></name>, <name><surname>Ferrucci</surname><given-names>L</given-names></name>, <name><surname>Tracy</surname><given-names>RP</given-names></name>, <name><surname>Corti</surname><given-names>MC</given-names></name>, <name><surname>Wacholder</surname><given-names>S</given-names></name>, <name><surname>Ettinger</surname><given-names>WH</given-names><suffix>Jr.</suffix></name>, <etal>et al</etal>
<article-title>Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly</article-title>. <source>Am J Med</source>. <year>1999</year>;<volume>106</volume>(<issue>5</issue>):<fpage>506</fpage>&#x02013;<lpage>12</lpage>. Epub 1999/05/21. .<pub-id pub-id-type="pmid">10335721</pub-id></mixed-citation></ref><ref id="pone.0185879.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Colbert</surname><given-names>LH</given-names></name>, <name><surname>Visser</surname><given-names>M</given-names></name>, <name><surname>Simonsick</surname><given-names>EM</given-names></name>, <name><surname>Tracy</surname><given-names>RP</given-names></name>, <name><surname>Newman</surname><given-names>AB</given-names></name>, <name><surname>Kritchevsky</surname><given-names>SB</given-names></name>, <etal>et al</etal>
<article-title>Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study</article-title>. <source>Journal of the American Geriatrics Society</source>. <year>2004</year>;<volume>52</volume>(<issue>7</issue>):<fpage>1098</fpage>&#x02013;<lpage>104</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1532-5415.2004.52307.x">10.1111/j.1532-5415.2004.52307.x</ext-link></comment> .<pub-id pub-id-type="pmid">15209647</pub-id></mixed-citation></ref><ref id="pone.0185879.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Geffken</surname><given-names>DF</given-names></name>, <name><surname>Cushman</surname><given-names>M</given-names></name>, <name><surname>Burke</surname><given-names>GL</given-names></name>, <name><surname>Polak</surname><given-names>JF</given-names></name>, <name><surname>Sakkinen</surname><given-names>PA</given-names></name>, <name><surname>Tracy</surname><given-names>RP</given-names></name>. <article-title>Association between physical activity and markers of inflammation in a healthy elderly population</article-title>. <source>Am J Epidemiol</source>. <year>2001</year>;<volume>153</volume>(<issue>3</issue>):<fpage>242</fpage>&#x02013;<lpage>50</lpage>. Epub 2001/02/07. .<pub-id pub-id-type="pmid">11157411</pub-id></mixed-citation></ref><ref id="pone.0185879.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Ford</surname><given-names>ES</given-names></name>. <article-title>Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults</article-title>. <source>Epidemiology</source>. <year>2002</year>;<volume>13</volume>(<issue>5</issue>):<fpage>561</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/01.EDE.0000023965.92535.C0">10.1097/01.EDE.0000023965.92535.C0</ext-link></comment> .<pub-id pub-id-type="pmid">12192226</pub-id></mixed-citation></ref><ref id="pone.0185879.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Kasapis</surname><given-names>C</given-names></name>, <name><surname>Thompson</surname><given-names>PD</given-names></name>. <article-title>The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review</article-title>. <source>J Am Coll Cardiol</source>. <year>2005</year>;<volume>45</volume>(<issue>10</issue>):<fpage>1563</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jacc.2004.12.077">10.1016/j.jacc.2004.12.077</ext-link></comment> .<pub-id pub-id-type="pmid">15893167</pub-id></mixed-citation></ref><ref id="pone.0185879.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Lambert</surname><given-names>CP</given-names></name>, <name><surname>Wright</surname><given-names>NR</given-names></name>, <name><surname>Finck</surname><given-names>BN</given-names></name>, <name><surname>Villareal</surname><given-names>DT</given-names></name>. <article-title>Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons</article-title>. <source>J Appl Physiol (1985)</source>
<year>2008</year>;<volume>105</volume>(<issue>2</issue>):<fpage>473</fpage>&#x02013;<lpage>8</lpage>. Epub 2008/06/07. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/japplphysiol.00006.2008">10.1152/japplphysiol.00006.2008</ext-link></comment> ; PubMed Central PMCID: PMCPMC2519937.<pub-id pub-id-type="pmid">18535122</pub-id></mixed-citation></ref><ref id="pone.0185879.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Nicklas</surname><given-names>BJ</given-names></name>, <name><surname>Hsu</surname><given-names>FC</given-names></name>, <name><surname>Brinkley</surname><given-names>TJ</given-names></name>, <name><surname>Church</surname><given-names>T</given-names></name>, <name><surname>Goodpaster</surname><given-names>BH</given-names></name>, <name><surname>Kritchevsky</surname><given-names>SB</given-names></name>, <etal>et al</etal>
<article-title>Exercise training and plasma C-reactive protein and interleukin-6 in elderly people</article-title>. <source>J Am Geriatr Soc</source>. <year>2008</year>;<volume>56</volume>(<issue>11</issue>):<fpage>2045</fpage>&#x02013;<lpage>52</lpage>. Epub 2008/11/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1532-5415.2008.01994.x">10.1111/j.1532-5415.2008.01994.x</ext-link></comment> ; PubMed Central PMCID: PMCPMC2683336.<pub-id pub-id-type="pmid">19016938</pub-id></mixed-citation></ref><ref id="pone.0185879.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Forti</surname><given-names>LN</given-names></name>, <name><surname>Njemini</surname><given-names>R</given-names></name>, <name><surname>Beyer</surname><given-names>I</given-names></name>, <name><surname>Eelbode</surname><given-names>E</given-names></name>, <name><surname>Meeusen</surname><given-names>R</given-names></name>, <name><surname>Mets</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Strength training reduces circulating interleukin-6 but not brain-derived neurotrophic factor in community-dwelling elderly individuals</article-title>. <source>Age</source>. <year>2014</year>;<volume>36</volume>(<issue>5</issue>):<fpage>9704</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11357-014-9704-6">10.1007/s11357-014-9704-6</ext-link></comment> .<pub-id pub-id-type="pmid">25128203</pub-id></mixed-citation></ref><ref id="pone.0185879.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Basu</surname><given-names>A</given-names></name>, <name><surname>Devaraj</surname><given-names>S</given-names></name>, <name><surname>Jialal</surname><given-names>I</given-names></name>. <article-title>Dietary factors that promote or retard inflammation</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2006</year>;<volume>26</volume>(<issue>5</issue>):<fpage>995</fpage>&#x02013;<lpage>1001</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.ATV.0000214295.86079.d1">10.1161/01.ATV.0000214295.86079.d1</ext-link></comment> .<pub-id pub-id-type="pmid">16484595</pub-id></mixed-citation></ref><ref id="pone.0185879.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Jialal</surname><given-names>I</given-names></name>, <name><surname>Devaraj</surname><given-names>S</given-names></name>, <name><surname>Venugopal</surname><given-names>SK</given-names></name>. <article-title>C-reactive protein: risk marker or mediator in atherothrombosis?</article-title>
<source>Hypertension</source>. <year>2004</year>;<volume>44</volume>(<issue>1</issue>):<fpage>6</fpage>&#x02013;<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.HYP.0000130484.20501.df">10.1161/01.HYP.0000130484.20501.df</ext-link></comment> .<pub-id pub-id-type="pmid">15148294</pub-id></mixed-citation></ref><ref id="pone.0185879.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Gonzalez</surname><given-names>R</given-names></name>, <name><surname>Ballester</surname><given-names>I</given-names></name>, <name><surname>Lopez-Posadas</surname><given-names>R</given-names></name>, <name><surname>Suarez</surname><given-names>MD</given-names></name>, <name><surname>Zarzuelo</surname><given-names>A</given-names></name>, <name><surname>Martinez-Augustin</surname><given-names>O</given-names></name>, <etal>et al</etal>
<article-title>Effects of flavonoids and other polyphenols on inflammation</article-title>. <source>Crit Rev Food Sci Nutr</source>. <year>2011</year>;<volume>51</volume>(<issue>4</issue>):<fpage>331</fpage>&#x02013;<lpage>62</lpage>. Epub 2011/03/25. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/10408390903584094">10.1080/10408390903584094</ext-link></comment> .<pub-id pub-id-type="pmid">21432698</pub-id></mixed-citation></ref><ref id="pone.0185879.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Biesalski</surname><given-names>HK</given-names></name>. <article-title>Polyphenols and inflammation: basic interactions</article-title>. <source>Curr Opin Clin Nutr Metab Care</source>. <year>2007</year>;<volume>10</volume>(<issue>6</issue>):<fpage>724</fpage>&#x02013;<lpage>8</lpage>. Epub 2007/12/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/MCO.0b013e3282f0cef2">10.1097/MCO.0b013e3282f0cef2</ext-link></comment> .<pub-id pub-id-type="pmid">18089954</pub-id></mixed-citation></ref><ref id="pone.0185879.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Medina-Remon</surname><given-names>A</given-names></name>, <name><surname>Casas</surname><given-names>R</given-names></name>, <name><surname>Tressserra-Rimbau</surname><given-names>A</given-names></name>, <name><surname>Ros</surname><given-names>E</given-names></name>, <name><surname>Martinez-Gonzalez</surname><given-names>MA</given-names></name>, <name><surname>Fito</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Polyphenol intake from a Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: A sub-study of The PREDIMED trial</article-title>. <source>Br J Clin Pharmacol</source>. <year>2016</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/bcp.12986">10.1111/bcp.12986</ext-link></comment> .<pub-id pub-id-type="pmid">27100393</pub-id></mixed-citation></ref><ref id="pone.0185879.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Ticinesi</surname><given-names>A</given-names></name>, <name><surname>Meschi</surname><given-names>T</given-names></name>, <name><surname>Lauretani</surname><given-names>F</given-names></name>, <name><surname>Felis</surname><given-names>G</given-names></name>, <name><surname>Franchi</surname><given-names>F</given-names></name>, <name><surname>Pedrolli</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Nutrition and Inflammation in Older Individuals: Focus on Vitamin D, n-3 Polyunsaturated Fatty Acids and Whey Proteins</article-title>. <source>Nutrients</source>. <year>2016</year>;<volume>8</volume>(<issue>4</issue>):<fpage>186</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/nu8040186">10.3390/nu8040186</ext-link></comment> ; PubMed Central PMCID: PMC4848655.<pub-id pub-id-type="pmid">27043616</pub-id></mixed-citation></ref><ref id="pone.0185879.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Haider</surname><given-names>S</given-names></name>, <name><surname>Dorner</surname><given-names>TE</given-names></name>, <name><surname>Luger</surname><given-names>E</given-names></name>, <name><surname>Kapan</surname><given-names>A</given-names></name>, <name><surname>Lackinger</surname><given-names>C</given-names></name>, <name><surname>Titze</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Impact of Home Visits with a Physical and Nutritional Intervention Program Conducted by Non-Professionals on Handgrip Strength, Physical Performance, and Muscle Mass in Prefrail and Frail Older Adults</article-title>. <source>PloS one</source>. Major revisions by <day>5</day>
<month>11</month>
<year>2016</year>.</mixed-citation></ref><ref id="pone.0185879.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Dale</surname><given-names>O</given-names></name>, <name><surname>Salo</surname><given-names>M</given-names></name>. <article-title>The Helsinki Declaration, research guidelines and regulations: present and future editorial aspects</article-title>. <source>Acta anaesthesiologica Scandinavica</source>. <year>1996</year>;<volume>40</volume>(<issue>7</issue>):<fpage>771</fpage>&#x02013;<lpage>2</lpage>. .<pub-id pub-id-type="pmid">8874560</pub-id></mixed-citation></ref><ref id="pone.0185879.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Dorner</surname><given-names>TE</given-names></name>, <name><surname>Lackinger</surname><given-names>C</given-names></name>, <name><surname>Haider</surname><given-names>S</given-names></name>, <name><surname>Luger</surname><given-names>E</given-names></name>, <name><surname>Kapan</surname><given-names>A</given-names></name>, <name><surname>Luger</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Nutritional intervention and physical training in malnourished frail community-dwelling elderly persons carried out by trained lay "buddies": study protocol of a randomized controlled trial</article-title>. <source>BMC Public Health</source>. <year>2013</year>;<volume>13</volume>(<issue>1</issue>):<fpage>1232</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2458-13-1232">10.1186/1471-2458-13-1232</ext-link></comment> .<pub-id pub-id-type="pmid">24369785</pub-id></mixed-citation></ref><ref id="pone.0185879.ref038"><label>38</label><mixed-citation publication-type="other">Randomizer for clinical trials 1.8.1. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.meduniwien.ac.at/randomizer/web/login.php">www.meduniwien.ac.at/randomizer/web/login.php</ext-link>.</mixed-citation></ref><ref id="pone.0185879.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Romero-Ortuno</surname><given-names>R</given-names></name>, <name><surname>Walsh</surname><given-names>CD</given-names></name>, <name><surname>Lawlor</surname><given-names>BA</given-names></name>, <name><surname>Kenny</surname><given-names>RA</given-names></name>. <article-title>A frailty instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE)</article-title>. <source>BMC Geriatr</source>. <year>2010</year>;<volume>10</volume>:<fpage>57</fpage> Epub 2010/08/25. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2318-10-57">10.1186/1471-2318-10-57</ext-link></comment> ; PubMed Central PMCID: PMC2939541.<pub-id pub-id-type="pmid">20731877</pub-id></mixed-citation></ref><ref id="pone.0185879.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Kaiser</surname><given-names>MJ</given-names></name>, <name><surname>Bauer</surname><given-names>JM</given-names></name>, <name><surname>Ramsch</surname><given-names>C</given-names></name>, <name><surname>Uter</surname><given-names>W</given-names></name>, <name><surname>Guigoz</surname><given-names>Y</given-names></name>, <name><surname>Cederholm</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status</article-title>. <source>J Nutr Health Aging</source>
<year>2009</year>;<volume>13</volume>(<issue>9</issue>):<fpage>782</fpage>&#x02013;<lpage>8</lpage>. Epub 2009/10/09. .<pub-id pub-id-type="pmid">19812868</pub-id></mixed-citation></ref><ref id="pone.0185879.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Folstein</surname><given-names>MF</given-names></name>, <name><surname>Folstein</surname><given-names>SE</given-names></name>, <name><surname>McHugh</surname><given-names>PR</given-names></name>. <article-title>"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.</article-title>
<source>J Psychiatr Res</source>. <year>1975</year>;<volume>12</volume>(<issue>3</issue>):<fpage>189</fpage>&#x02013;<lpage>98</lpage>. Epub 1975/11/01. .<pub-id pub-id-type="pmid">1202204</pub-id></mixed-citation></ref><ref id="pone.0185879.ref042"><label>42</label><mixed-citation publication-type="book"><name><surname>Segen</surname><given-names>J</given-names></name>. <source>Segen's Medical Dictionary</source>: <publisher-name>Farlex Inc.</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="pone.0185879.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Rolland</surname><given-names>Y</given-names></name>, <name><surname>Dupuy</surname><given-names>C</given-names></name>, <name><surname>Abellan van Kan</surname><given-names>G</given-names></name>, <name><surname>Gillette</surname><given-names>S</given-names></name>, <name><surname>Vellas</surname><given-names>B</given-names></name>. <article-title>Treatment strategies for sarcopenia and frailty</article-title>. <source>Med Clin North Am</source>. <year>2011</year>;<volume>95</volume>(<issue>3</issue>):<fpage>427</fpage>&#x02013;<lpage>38</lpage>, ix. Epub 2011/05/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.mcna.2011.02.008">10.1016/j.mcna.2011.02.008</ext-link></comment> .<pub-id pub-id-type="pmid">21549870</pub-id></mixed-citation></ref><ref id="pone.0185879.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Ng</surname><given-names>TP</given-names></name>, <name><surname>Feng</surname><given-names>L</given-names></name>, <name><surname>Nyunt</surname><given-names>MS</given-names></name>, <name><surname>Feng</surname><given-names>L</given-names></name>, <name><surname>Niti</surname><given-names>M</given-names></name>, <name><surname>Tan</surname><given-names>BY</given-names></name>, <etal>et al</etal>
<article-title>Nutritional, Physical, Cognitive, and Combination Interventions and Frailty Reversal Among Older Adults: A Randomized Controlled Trial</article-title>. <source>Am J Med</source>. <year>2015</year>;<volume>128</volume>(<issue>11</issue>):<fpage>1225</fpage>&#x02013;<lpage>36 e1</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.amjmed.2015.06.017">10.1016/j.amjmed.2015.06.017</ext-link></comment> .<pub-id pub-id-type="pmid">26159634</pub-id></mixed-citation></ref><ref id="pone.0185879.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Romero-Arenas</surname><given-names>S</given-names></name>, <name><surname>Martinez-Pascual</surname><given-names>M</given-names></name>, <name><surname>Alcaraz</surname><given-names>PE</given-names></name>. <article-title>Impact of resistance circuit training on neuromuscular, cardiorespiratory and body composition adaptations in the elderly</article-title>. <source>Aging Dis</source>. <year>2013</year>;<volume>4</volume>(<issue>5</issue>):<fpage>256</fpage>&#x02013;<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.14336/AD.2013.0400256">10.14336/AD.2013.0400256</ext-link></comment> ; PubMed Central PMCID: PMC3794722.<pub-id pub-id-type="pmid">24124631</pub-id></mixed-citation></ref><ref id="pone.0185879.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Bonnefoy</surname><given-names>M</given-names></name>, <name><surname>Berrut</surname><given-names>G</given-names></name>, <name><surname>Lesourd</surname><given-names>B</given-names></name>, <name><surname>Ferry</surname><given-names>M</given-names></name>, <name><surname>Gilbert</surname><given-names>T</given-names></name>, <name><surname>Guerin</surname><given-names>O</given-names></name>, <etal>et al</etal>
<article-title>Frailty and nutrition: searching for evidence</article-title>. <source>J Nutr Health Aging</source>. <year>2015</year>;<volume>19</volume>(<issue>3</issue>):<fpage>250</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s12603-014-0568-3">10.1007/s12603-014-0568-3</ext-link></comment> .<pub-id pub-id-type="pmid">25732208</pub-id></mixed-citation></ref><ref id="pone.0185879.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Bauer</surname><given-names>J</given-names></name>, <name><surname>Biolo</surname><given-names>G</given-names></name>, <name><surname>Cederholm</surname><given-names>T</given-names></name>, <name><surname>Cesari</surname><given-names>M</given-names></name>, <name><surname>Cruz-Jentoft</surname><given-names>AJ</given-names></name>, <name><surname>Morley</surname><given-names>JE</given-names></name>, <etal>et al</etal>
<article-title>Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group</article-title>. <source>J Am Med Dir Assoc</source>
<year>2013</year>;<volume>14</volume>(<issue>8</issue>):<fpage>542</fpage>&#x02013;<lpage>59</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jamda.2013.05.021">10.1016/j.jamda.2013.05.021</ext-link></comment> .<pub-id pub-id-type="pmid">23867520</pub-id></mixed-citation></ref><ref id="pone.0185879.ref048"><label>48</label><mixed-citation publication-type="other">University of Harvard. Healthy eating plate. [19 July 2013]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.hsph.harvard.edu/nutritionsource/healthy-eating-plate/">www.hsph.harvard.edu/nutritionsource/healthy-eating-plate/</ext-link>.</mixed-citation></ref><ref id="pone.0185879.ref049"><label>49</label><mixed-citation publication-type="book"><name><surname>Thomas</surname><given-names>L</given-names></name>, <name><surname>Ansorg</surname><given-names>R</given-names></name>, <name><surname>Arndt</surname><given-names>T</given-names></name>, <name><surname>Barlage</surname><given-names>T</given-names></name>. <source>Labor und Diagnose: Indikation und Bewertung von Laborbefunden f&#x000fc;r die medizinische Diagnostik</source> (<edition>7. edition</edition>). <publisher-loc>Frankfurt</publisher-loc>: <publisher-name>TH-Books-Verlag-Ges.</publisher-name>; <year>2008</year>.</mixed-citation></ref><ref id="pone.0185879.ref050"><label>50</label><mixed-citation publication-type="other">Data Input. Das B.I.A.-Kompendium (3. edition) Darmstadt2009 [19. July 2016]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.datainput.de/media/pdf-deutsch/Kompendium_III_Ausgabe_2009.pdf">www.datainput.de/media/pdf-deutsch/Kompendium_III_Ausgabe_2009.pdf</ext-link>.</mixed-citation></ref><ref id="pone.0185879.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Kyle</surname><given-names>UG</given-names></name>, <name><surname>Genton</surname><given-names>L</given-names></name>, <name><surname>Karsegard</surname><given-names>L</given-names></name>, <name><surname>Slosman</surname><given-names>DO</given-names></name>, <name><surname>Pichard</surname><given-names>C</given-names></name>. <article-title>Single prediction equation for bioelectrical impedance analysis in adults aged 20&#x02013;94 years</article-title>. <source>Nutrition</source>. <year>2001</year>;<volume>17</volume>(<issue>3</issue>):<fpage>248</fpage>&#x02013;<lpage>53</lpage>. Epub 2001/04/20. .<pub-id pub-id-type="pmid">11312069</pub-id></mixed-citation></ref><ref id="pone.0185879.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Genton</surname><given-names>L</given-names></name>, <name><surname>Karsegard</surname><given-names>V</given-names></name>, eacute, ronique L, <name><surname>Kyle</surname><given-names>UG</given-names></name>, <name><surname>Hans</surname><given-names>DB</given-names></name>, <etal>et al</etal>
<article-title>Comparison of Four Bioelectrical Impedance Analysis Formulas in Healthy Elderly Subjects</article-title>. <source>Gerontology</source>. <year>2001</year>;<volume>47</volume>(<issue>6</issue>):<fpage>315</fpage>&#x02013;<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1159/000052821">10.1159/000052821</ext-link></comment>
<pub-id pub-id-type="pmid">11721145</pub-id></mixed-citation></ref><ref id="pone.0185879.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Sergi</surname><given-names>G</given-names></name>, <name><surname>De Rui</surname><given-names>M</given-names></name>, <name><surname>Veronese</surname><given-names>N</given-names></name>, <name><surname>Bolzetta</surname><given-names>F</given-names></name>, <name><surname>Berton</surname><given-names>L</given-names></name>, <name><surname>Carraro</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults</article-title>. <source>Clin Nutr</source>. <year>2015</year>;<volume>34</volume>(<issue>4</issue>):<fpage>667</fpage>&#x02013;<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clnu.2014.07.010">10.1016/j.clnu.2014.07.010</ext-link></comment> .<pub-id pub-id-type="pmid">25103151</pub-id></mixed-citation></ref><ref id="pone.0185879.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Roberts</surname><given-names>HC</given-names></name>, <name><surname>Denison</surname><given-names>HJ</given-names></name>, <name><surname>Martin</surname><given-names>HJ</given-names></name>, <name><surname>Patel</surname><given-names>HP</given-names></name>, <name><surname>Syddall</surname><given-names>H</given-names></name>, <name><surname>Cooper</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach</article-title>. <source>Age Ageing</source>. <year>2011</year>;<volume>40</volume>(<issue>4</issue>):<fpage>423</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/ageing/afr051">10.1093/ageing/afr051</ext-link></comment> .<pub-id pub-id-type="pmid">21624928</pub-id></mixed-citation></ref><ref id="pone.0185879.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Guralnik</surname><given-names>JM</given-names></name>, <name><surname>Simonsick</surname><given-names>EM</given-names></name>, <name><surname>Ferrucci</surname><given-names>L</given-names></name>, <name><surname>Glynn</surname><given-names>RJ</given-names></name>, <name><surname>Berkman</surname><given-names>LF</given-names></name>, <name><surname>Blazer</surname><given-names>DG</given-names></name>, <etal>et al</etal>
<article-title>A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission</article-title>. <source>J Gerontol</source>
<year>1994</year>;<volume>49</volume>(<issue>2</issue>):<fpage>M85</fpage>&#x02013;<lpage>94</lpage>. Epub 1994/03/01. .<pub-id pub-id-type="pmid">8126356</pub-id></mixed-citation></ref><ref id="pone.0185879.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Charlson</surname><given-names>ME</given-names></name>, <name><surname>Pompei</surname><given-names>P</given-names></name>, <name><surname>Ales</surname><given-names>KL</given-names></name>, <name><surname>MacKenzie</surname><given-names>CR</given-names></name>. <article-title>A new method of classifying prognostic comorbidity in longitudinal studies: development and validation</article-title>. <source>J Chronic Dis</source>. <year>1987</year>;<volume>40</volume>(<issue>5</issue>):<fpage>373</fpage>&#x02013;<lpage>83</lpage>. Epub 1987/01/01. .<pub-id pub-id-type="pmid">3558716</pub-id></mixed-citation></ref><ref id="pone.0185879.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>S</given-names></name>, <name><surname>Paul</surname><given-names>J</given-names></name>, <name><surname>Nantha-Aree</surname><given-names>M</given-names></name>, <name><surname>Buckley</surname><given-names>N</given-names></name>, <name><surname>Shahzad</surname><given-names>U</given-names></name>, <name><surname>Cheng</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Empirical comparison of four baseline covariate adjustment methods in analysis of continuous outcomes in randomized controlled trials</article-title>. <source>Clin Epidemiol</source>
<year>2014</year>;<volume>6</volume>:<fpage>227</fpage>&#x02013;<lpage>35</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2147/CLEP.S56554">10.2147/CLEP.S56554</ext-link></comment> ; PubMed Central PMCID: PMC4105274.<pub-id pub-id-type="pmid">25053894</pub-id></mixed-citation></ref><ref id="pone.0185879.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Shrivastava</surname><given-names>AK</given-names></name>, <name><surname>Singh</surname><given-names>HV</given-names></name>, <name><surname>Raizada</surname><given-names>A</given-names></name>, <name><surname>Singh</surname><given-names>SK</given-names></name>, <name><surname>Pandey</surname><given-names>A</given-names></name>, <name><surname>Singh</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Inflammatory markers in patients with rheumatoid arthritis</article-title>. <source>Allergologia et immunopathologia</source>. <year>2015</year>;<volume>43</volume>(<issue>1</issue>):<fpage>81</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.aller.2013.11.003">10.1016/j.aller.2013.11.003</ext-link></comment> .<pub-id pub-id-type="pmid">24656623</pub-id></mixed-citation></ref><ref id="pone.0185879.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Leong</surname><given-names>DP</given-names></name>, <name><surname>Teo</surname><given-names>KK</given-names></name>, <name><surname>Rangarajan</surname><given-names>S</given-names></name>, <name><surname>Kutty</surname><given-names>VR</given-names></name>, <name><surname>Lanas</surname><given-names>F</given-names></name>, <name><surname>Hui</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Reference ranges of handgrip strength from 125,462 healthy adults in 21 countries: a prospective urban rural epidemiologic (PURE) study</article-title>. <source>Journal of cachexia, sarcopenia and muscle</source>. <year>2016</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jcsm.12112">10.1002/jcsm.12112</ext-link></comment> ; PubMed Central PMCID: PMC4833755.<pub-id pub-id-type="pmid">27104109</pub-id></mixed-citation></ref><ref id="pone.0185879.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Haider</surname><given-names>S</given-names></name>, <name><surname>Dorner</surname><given-names>TE</given-names></name>, <name><surname>Luger</surname><given-names>E</given-names></name>, <name><surname>Kapan</surname><given-names>A</given-names></name>, <name><surname>Titze</surname><given-names>S</given-names></name>, <name><surname>Lackinger</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Impact of a Home-Based Physical and Nutritional Intervention Program Conducted by Lay-Volunteers on Handgrip Strength in Prefrail and Frail Older Adults: A Randomized Control Trial</article-title>. <source>PloS one</source>. <year>2017</year>;<volume>12</volume>(<issue>1</issue>):<fpage>e0169613</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0169613">10.1371/journal.pone.0169613</ext-link></comment> .<pub-id pub-id-type="pmid">28085913</pub-id></mixed-citation></ref><ref id="pone.0185879.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Nicklas</surname><given-names>BJ</given-names></name>, <name><surname>Ambrosius</surname><given-names>W</given-names></name>, <name><surname>Messier</surname><given-names>SP</given-names></name>, <name><surname>Miller</surname><given-names>GD</given-names></name>, <name><surname>Penninx</surname><given-names>BW</given-names></name>, <name><surname>Loeser</surname><given-names>RF</given-names></name>, <etal>et al</etal>
<article-title>Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial</article-title>. <source>Am J Clin Nutr</source>. <year>2004</year>;<volume>79</volume>(<issue>4</issue>):<fpage>544</fpage>&#x02013;<lpage>51</lpage>. Epub 2004/03/31. .<pub-id pub-id-type="pmid">15051595</pub-id></mixed-citation></ref><ref id="pone.0185879.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>DeRijk</surname><given-names>R</given-names></name>, <name><surname>Michelson</surname><given-names>D</given-names></name>, <name><surname>Karp</surname><given-names>B</given-names></name>, <name><surname>Petrides</surname><given-names>J</given-names></name>, <name><surname>Galliven</surname><given-names>E</given-names></name>, <name><surname>Deuster</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6</article-title>. <source>J Clin Endocrinol Metab</source>. <year>1997</year>;<volume>82</volume>(<issue>7</issue>):<fpage>2182</fpage>&#x02013;<lpage>91</lpage>. Epub 1997/07/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jcem.82.7.4041">10.1210/jcem.82.7.4041</ext-link></comment> .<pub-id pub-id-type="pmid">9215292</pub-id></mixed-citation></ref><ref id="pone.0185879.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Podor</surname><given-names>TJ</given-names></name>, <name><surname>Jirik</surname><given-names>FR</given-names></name>, <name><surname>Loskutoff</surname><given-names>DJ</given-names></name>, <name><surname>Carson</surname><given-names>DA</given-names></name>, <name><surname>Lotz</surname><given-names>M</given-names></name>. <article-title>Human endothelial cells produce IL-6. Lack of responses to exogenous IL-6</article-title>. <source>Annals of the New York Academy of Sciences</source>. <year>1989</year>;<volume>557</volume>:<fpage>374</fpage>&#x02013;<lpage>85</lpage>; discussion 86&#x02013;7. Epub 1989/01/01. .<pub-id pub-id-type="pmid">2660697</pub-id></mixed-citation></ref><ref id="pone.0185879.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Schroder</surname><given-names>H</given-names></name>, <name><surname>Fito</surname><given-names>M</given-names></name>, <name><surname>Estruch</surname><given-names>R</given-names></name>, <name><surname>Martinez-Gonzalez</surname><given-names>MA</given-names></name>, <name><surname>Corella</surname><given-names>D</given-names></name>, <name><surname>Salas-Salvado</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women</article-title>. <source>The Journal of nutrition</source>. <year>2011</year>;<volume>141</volume>(<issue>6</issue>):<fpage>1140</fpage>&#x02013;<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3945/jn.110.135566">10.3945/jn.110.135566</ext-link></comment> .<pub-id pub-id-type="pmid">21508208</pub-id></mixed-citation></ref><ref id="pone.0185879.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Norman</surname><given-names>K</given-names></name>, <name><surname>Stobaus</surname><given-names>N</given-names></name>, <name><surname>Pirlich</surname><given-names>M</given-names></name>, <name><surname>Bosy-Westphal</surname><given-names>A</given-names></name>. <article-title>Bioelectrical phase angle and impedance vector analysis&#x02014;clinical relevance and applicability of impedance parameters</article-title>. <source>Clinical nutrition</source>. <year>2012</year>;<volume>31</volume>(<issue>6</issue>):<fpage>854</fpage>&#x02013;<lpage>61</lpage>. Epub 2012/06/16. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clnu.2012.05.008">10.1016/j.clnu.2012.05.008</ext-link></comment> .<pub-id pub-id-type="pmid">22698802</pub-id></mixed-citation></ref><ref id="pone.0185879.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Soysal</surname><given-names>P</given-names></name>, <name><surname>Isik</surname><given-names>AT</given-names></name>, <name><surname>Carvalho</surname><given-names>AF</given-names></name>, <name><surname>Fernandes</surname><given-names>BS</given-names></name>, <name><surname>Solmi</surname><given-names>M</given-names></name>, <name><surname>Schofield</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Oxidative stress and frailty: A systematic review and synthesis of the best evidence</article-title>. <source>Maturitas</source>. <year>2017</year>;<volume>99</volume>:<fpage>66</fpage>&#x02013;<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.maturitas.2017.01.006">10.1016/j.maturitas.2017.01.006</ext-link></comment> .<pub-id pub-id-type="pmid">28364871</pub-id></mixed-citation></ref></ref-list></back></article>